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Abstract 
Telomerase is the ribonucleoprotein complex that replenishes lost DNA sequences at the 
ends of chromosomes. At its core, telomerase consists of an RNA subunit (TERC) that 
provides the template and a catalytic protein component (TERT). Insufficient telomerase 
activity leads to various disorders like dyskeratosis congenita, aplastic anemia and 
idiopathic pulmonary fibrosis.  How different mutations in the same gene lead to 
disparate symptoms and disorders is not clear. The overall objective of my project is to 
understand the biogenesis of telomerase in the genetically tractable eukaryote S. pombe, 
whose telomere maintenance machinery closely resembles that of humans. Our 
laboratory has previously shown that the mature 3’ end of S. pombe telomerase RNA 
(TER1) is generated by the first step of spliceosomal splicing. The cis- and trans- acting 
factors that distinguish the single step spliceosomal cleavage in TER1 from the two-step 
splicing reaction that removes introns in other genes are being investigated. We now 
demonstrate that a strong branch site (BS), a long distance to the 3’ splice site (SS) and a 
weak polypyrimidine tract (Py) tract act synergistically to attenuate the transition from 
the first to the second step of splicing. The observation that a strong BS antagonizes the 
second step of splicing in the context of TER1 suggests that the BS-U2 snRNA 
interactions are disrupted after the first step and thus earlier than previously thought. The 
slow transition from first to second step triggers the Prp22 DExD/H-box helicase- 
dependent rejection of the cleaved products and Prp43-dependent discard of the splicing 
intermediates. Related to this work, we have established that the spliceosome generates 
the 3’ ends of telomerase RNA in S. cryophilus and S. octosporus albeit via a different 
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mechanism involving U6 snRNA hyperstabilization at the 5’ss. Our findings explain how 
the spliceosome can function in 3’ end processing and provide new insights into the 
mechanism of splicing. 
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Chapter I:  
Introduction to telomerase and significance of research 
I.1:Introduction to telomeres and telomerase  
The genetic information that dictates the functions of a cell is packed in a thread like 
structure called chromosome. Within the nucleus, chromosomes are maintained in either 
circular or linear state. Though, circular chromosomes predominate in bacteria and 
archaea [1], eukaryotes exclusively maintain linear chromosomes due to their pivotal role 
in productive meiosis and for accommodating their genomic complexity [2]. In spite of 
these advantages, evolution of linear chromosomes in eukaryotes poses two perennial 
problems: 
A. End protection problem 
B. End replication problem 
I.1.a: The first problem with linear ends: ‘End protection’ problem 
Cells encounter wide variety of stress and mutagenic insults like UV light, genotoxic 
chemicals, radiation and reactive oxygen species. Each of these insults can alter DNA 
sequences and generate double strand break (DSB) thereby affecting the output of the 
genetic code, namely RNA and protein. To avoid accumulation of hazardous mutations, 
cells have developed numerous DNA repair pathways [3, 4]. As the mechanisms for 
fixing DSB were being deciphered, it became clear that the repair pathways recognize 
linear DNA molecules as a signal for broken DNA ends. In light of this finding, an 
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important question arose - Are linear chromosome ends sensed as DSB within the cell, or 
if not, how do they evade these repair pathways [5]?  
I.1.b: Linear chromosome ends are shielded from DNA repair 
Pioneering studies from McClintock and Muller established critical differences between 
behavior of linear chromosome ends and that of broken DNA. McClintock documented 
that, although double strand breaks are efficiently repaired by the cell, naturally occurring 
chromosome termini are immune to this process [6]. Muller reported similar findings and 
coined the term ‘telomere’ from the Greek words telos (end) and meros (part)[7].  
One of the first insights regarding the function of telomeres came from Szostak and 
colleagues who demonstrated that linear DNA introduced into eukaryotes is unstable, 
because it recombines with the genome [8]. We now know that linear DNA is subject to 
two major repair pathways that mend DSB: Homology Directed Repair (HDR) and Non 
Homologous End Joining (NHEJ) [4, 9, 10].  
A second breakthrough came from the work of Hartwell and colleagues who established 
that budding yeast cells lacking RAD9 failed to arrest the cell cycle in response to DSB 
[11]. Similar studies carried out in fission yeast and mammals further reinforced the idea 
that broken chromosomes by themselves are not triggering cell cycle arrest [12]. Rather, 
there are molecular pathways that sense double strand breaks and arrest cell cycle. Work 
over the past two decades has established that two conserved independent signaling 
pathways are activated by double-strand breaks: (i) the ATM (ataxia telangiectasia 
mutated) kinase pathway, which is directly activated by DNA ends, and (ii) the ATR 
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(ataxia telangiectasia and Rad3 related) kinase pathway, which senses the single-stranded 
DNA formed as a result of 5′ end resection of a double-strand break [5]. Based on these 
observations, a critical question arose: how chromosome ends inhibit these molecular 
pathways? 
	  
Figure 1.1: How telomeres solve ‘The end-protection problem’. Adapted from [5]. A 
DNA break in mammalian chromosome (top) generates exposed DNA ends that can 
activate two signaling pathways (the ATM and ATR kinase pathways). These distinct 
pathways arrest the cell division cycle and can induce cell death. Either NHEJ or HDR 
pathways repair DSB, allowing normal progression of cell cycle. The presence of DNA 
damage response pathways is a perennial problem for the linear ends of chromosome 
(telomeres, bottom) because activation of DNA damage signaling or DNA repair at 
telomeres would be disastrous. Mammalian telomeres solve this end-protection problem 
through the use of a telomere-specific protein complex (shelterin) and an altered structure 
(the t-loop, pictured in the EM) that together safeguard linear chromosome ends. 
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I.1.c: Telomeres protect chromosome ends from DNA repair & degradation 
Seminal studies from Blackburn & Szostak demonstrated that telomeres from the ciliate 
Tetrahymena can stabilize linear ends of yeast artificial chromosomes illustrating that the 
protective function of telomere is conserved across diverse species [13]. We now know 
‘telomeres’ are nucleo-protein complexes that safeguard chromosome termini against 
erosion and illegitimate recombination events. Mammalian chromosomes end in tandem 
repeats of TTAGGG that ranges in size from 10-15 kilobases in humans to 20-60 
kilobases in mice [14, 15].  A unique requirement of telomeric DNA is the presence of a 
single stranded 3’ overhang which has been proposed to invade the double stranded 
region, thereby sequestering it from exposure to exonucleases [16]. In addition, 
specialized proteins recognize the single-stranded and double-stranded portions, coating 
telomeres to form a cap like structure. Telomeric Repeat Binding Factor 1 and 2 (TRF1 & 
TRF2) bind the double stranded part in a sequence specific fashion [17, 18]. TRF1 and 
TRF2 recruit TIN2 and RAP1 respectively [19, 20]. The single stranded region of 
telomeres is bound by POT1/TPP1 complex [21-25]. Together, these six proteins are 
referred to as ‘Shelterin’ [26]. Shelterin components have specific roles in chromosomal 
end protection and maintenance.  
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  Figure 1.2: Schematic of human chromosome termini with telomere binding proteins. 
Human chromosome is shown in purple with telomeres highlighted in orange (left), 
adapted from Nobel Prize press release, 2009. The shelterin components in humans and 
S. pombe are depicted (right). 
	  
Repression of the ATM pathway is largely mediated by TRF2 [27]. Loss of TRF2 leads 
to ATM activation at natural chromosome ends, which can be visualized by telomeric 
localization of DNA Damage response proteins like 53BP1 and H2AX [28, 29]. 
Similarly, removal of POT1 triggers ATR signaling pathway, which results in 
phosphorylation of the downstream effectors Chk1 and Chk2 [30, 31]. Although, TRF2 is 
sufficient for mitigating the threat provided by NHEJ in mouse [32], studies in humans 
have implicated a role for both TRF2 and RAP1 [33, 34].  
Rap1 Rap1
TRF1/2 TRF1/2
Tin2 Tpp1
Pot1 3’
Rap1
Pot1 3’
Rif1
Ccq1Poz Tpz1
Taz1 Taz1
Mammals
Schizosaccharomyces pombe
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Apart from chromosome end protection, shelterin components have additional telomere 
related functions. TRF1 has been shown to promote efficient replication of repeats and 
prevents replicative fork stalling [35]. In light of recent studies, it is evident that TPP1 is 
essential for recruiting telomerase to chromosome ends in addition to its canonical 
function in end protection [24, 36, 37]. In summary, by recruiting shelterin proteins to the 
ends of all chromosomes, eukaryotes have developed an ingenious method to block the 
DNA repair machinery and safeguard the genome [5]. 
I.1.d: The second problem with linear ends: End replication problem 
A second issue with linear DNA stems from inherent limitations of the DNA replication 
machinery. Semi-conservative replication can synthesize DNA only in the 5’-3’ direction 
and the DNA polymerase requires binding of an RNA primer (Fig 1.3a). Thus, as the 
replication fork moves along the chromosome, there is a discord in the synthesis of the 
two strands. While one of the two daughter strands is synthesized continuously, the other 
daughter strand, known as the lagging strand, is synthesized discontinuously as short 
DNA fragments known as Okazaki fragments, each of which has its own RNA primer. 
The RNA primers are subsequently degraded, and the gaps between the Okazaki 
fragments are then filled in. A problem arises at the end of the chromosome, because the 
DNA repair machinery is unable to repair the gap left by the terminal RNA primer. 
Consequently, the new DNA molecule is shorter than the parent DNA molecule by at 
least the length of one RNA primer. In the absence of any solution, telomere shortening 
leads to replicative senescence, a physiological state in which no further cell division can 
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occur. This phenomenon predicted independently by James Watson & Alexander 
Olovnikov, is referred to as the ‘end replication problem’ [38-40], and is widely 
considered as a potent tumor suppressive mechanism for somatic cells. On the other 
hand, stem cells and rapidly proliferating cells require continued cell division and a 
strategy to replenish telomere length. 
independently hypothesized by Jim Watson and A. Olovnikov in the 1970s, is one of 
the most fundamental and interesting problems in biology [91, 92]. 
Removal of RNA primer (red) recreates G-
overhang 
G-overhang Elongation by Telomerase 
Semi-conservative DNA Synthesis 
Degradation of C-rich Strand 
Leading Strand Synthesis 
Removal of RNA primer (red) 
creates ss gap at end 
Lagging Strand Synthesis 
Leading Strand Synthesis 
 
Figure 1.5: (a) Representation of the “end replication problem”. (b) Generation of 
single-stranded overhangs and elongation by telomerase counteracts the “end 
replication problem”. Adapted from [93] with permission from Nature Publishing 
Group. 
 
 
I.4b: Telomerase counteracts the end-replication problem 
 Of course, since all eukaryotes have linear chromosomes, these cells must 
contain a mechanism to counteract the end replication problem. The ingenious 
solution in most cases is provided by a reverse-transcriptase enzyme called 
telomerase [94]. This enzyme is comprised of both protein and RNA components, 
 38
 
 
Figure 1.3: Telomerase counteracts telomere shortening in most of the eukaryotes.          
a) Conventional DNA polymerases synthesize DNA in the 5' 3' direction and require a 
3’OH group provided by an 8–12-base segment of RNA as a primer (red). The leading 
strand is synthesized continuously (green). In contrast, the lagging strand is synthesized 
in short, RNA-primed OKAZAKI FRAGMENTS (blue). After extension, the primers are 
removed and the gaps filled in by DNA polymerase priming from upstream DNA 3' ends. 
Removal of the 5'-most RNA primer generates an 8–12-base gap. Failure to fill in this 
gap leads to a small loss of DNA in each round of DNA replication. b) How telomerase 
solves the end replication problem.Telomere shortening after each round of replication 
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and resection of lagging strand by exonucleases, generates a 3’ overhang which serves as 
primer for telomerase mediated telomere extension of the leading strand.This allows 
DNA replication machinery to fill in the lagging strand and overcome telomere 
shortening. Adapted from [41]. 
I.1.e: Telomerase solves the end replication problem 
Pioneering experiments from Greider and Blackburn established that Tetrahymena cell 
extract could extend short telomeric DNA sequences in vitro, proving the existence of a 
special polymerase within the cells which was subsequently named ‘Telomerase’ [42].  
We now know that telomerase is a large ribonucleoprotein (RNP) complex that 
synthesizes and maintains telomeres at the ends of linear chromosomes. The catalytic 
core of this complex contains an essential RNA component that serves as template for 
telomere synthesis (telomerase RNA – TER) and a unique reverse transcriptase protein 
(telomerase reverse transcriptase – Tert)[43, 44]. The widespread adoption of telomerase 
as the main strategy to counter telomere shortening illustrates the pivotal role of the 
enzyme in maintaining genomic integrity and cellular proliferation. Indeed, abnormal 
expression of telomerase components leads to cancer and wide variety of degenerative 
disorders as mentioned below. 
I.1.f: Telomeres and telomerase associated human diseases 
An early indicator that telomeres were crucial for cancer progression came from 
examining primary human fibroblasts grown in cell culture. With completion of ~60–80 
population doublings these cells entered into senescence [45]. In contrast, established 
cancer lines divided indefinitely with passage in culture. A vital clue came with the 
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observation that telomeres shorten progressively during division of normal human 
fibroblasts in culture, yet are maintained in cancer cells [46]. Consequently, these 
shortened telomeres activate a ‘senescence’ program; however, this growth arrest 
phenotype can be neutralized through inactivation of p53 and Rb (the Retinoblastoma 
tumor suppressor protein) [47, 48]. Senescence in these fibroblasts is effectively averted 
by overexpression of telomerase reverse transcriptase (TERT) [49]. Considering these 
results, it is not surprising that highly recurrent mutations in TERT promoter, up-
regulating telomerase levels, have been detected in wide variety of skin cancers [50, 51]. 
In essence, these observations suggest that high amounts of telomerase are essential for 
cancer development and progression, making it an attractive target for pharmaceutical 
manipulations and cancer treatment [52]. 
Equally important, shortening of telomeres has been shown to contribute broadly to aging 
& senescence [53]. In patients with germline mutations in genes controlling telomere 
maintenance, telomere shortening caused a range of disease phenotypes including 
dyskeratosis congenita (DC), pulmonary fibrosis and aplastic anemia. Dyskeratosis 
congenita is the most severe form of the ‘telomere diseases’ and is characterized by a 
classic triad of symptoms including abnormal skin pigmentation; nail dystrophy and oral 
leukoplakia [54-56]. DC causing mutations have been identified not only in the catalytic 
components TER [56] and TERT [57], but also other components of telomerase critical 
for stability [55, 58] and localization [59, 60]. To elucidate the mechanism behind 
dyskeratosis congenita, patient specific induced pluripotent stem cells (IPSc) have been 
generated. Unlike control samples, patient iPS cells displayed higher tendency to 
	   24	  
differentiate and lesser ability to self renew [61]. Thus a possible mechanism of 
dyskeratosis congenita could be exhaustion of stem cells and their inability to divide due 
to short telomeres.  
Although we are beginning to conceive how telomerase mutations causes degenerative 
disorders, it is not clear why different mutations in the same gene lead to disparate 
symptoms and disorders. For a complete understanding of telomere and telomerase 
associated disorders, it is imperative to elucidate how the correct amount of telomerase is 
made.  
Although the catalytic activity of telomerase requires only TER and TERT, other proteins 
in the holoenzyme complex regulate complex assembly, trafficking, and stability. 
Consequently, cellular telomerase holoenzymes are multi-subunit complexes with an 
apparent mass of 500 kDa or more as estimated by gel fractionation studies[62, 63]. 
Though the telomerase holoenzyme proteins and their exact mechanisms of function 
differ between organisms, some of their biochemical roles bear significant 
similarities[62]. Next, I will describe the similarities and differences of telomerase RNA 
biogenesis and RNP assembly from ciliates, yeasts, and vertebrates.	  
I.2.a: Telomerase RNA biogenesis in Ciliates 
Blackburn and Greider identified telomerase activity using extracts prepared from ciliates 
[42]. In addition, telomerase was first purified from Euplotes aediculatus by affinity 
chromatography which led to the identification of the catalytic subunit TERT [44] and a 
La-motif protein p43[43]. Though the function of p43 has been characterized only 
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biochemically [64-66] and its in vivo function is still unclear, it was crucial in 
identification of its homolog, p65 in Tetrahymena thermophila, which is necessary for 
TERT and TER accumulation in vivo [67]. 
Ciliate telomerase RNA is transcribed by RNA polymerase III [68] and mature TER 
terminates with a 3′ uridine-rich sequence. In T. thermophila, the TER 3′ polyuridine tail 
along with preceding RNA stems, provide a binding site for the telomerase-specific p65 
protein. In addition, binding of p65 to telomerase RNA changes RNA conformation to 
promote TERT assembly and catalytic activity [69].	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Figure 1.4: Schematic of telomerase RNA (TER) biogenesis in T. Thermophila. TER is 
transcribed by RNA polymerase III. The binding of p65 alters conformation of stem IV 
that enhances TERT binding. The p65-TER-TERT ternary complex then interacts with a 
complex of p75, p50, p45 and p19 that recruit the single-stranded telomeric DNA-binding 
protein Teb1, which provides a stable grip on DNA and promotes telomerase activity. 
Adapted from [62]. 
I.2.b: Telomerase RNA biogenesis in Yeast 
In contrast to ciliates, budding yeast telomerase RNA (TLC1) is transcribed by RNA pol 
II and the mature form is non-polyadenylated [70]. Although, longer forms of TLC1 that 
are polyadenylated have been identified, their function remains elusive [70].  
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Surprisingly, the 3′ end of functional TLC1 is generated independently of the longer 
transcript. In this case, Nrd1–Nab3–Sen1 pathway is required for transcription 
termination and 3’ end formation of TLC1[71].  
In general, the transcription termination pathway mediated by Nrd1-Nab3-Sen1 has been 
well studied in budding yeast[72]. Binding to the C-terminal domain (CTD) of RNA Pol 
II, Nrd1 and Nab3 recognize sequences in the precursor transcript downstream from the 
mature RNA 3′ end. They interact with the Sen1 helicase, which is thought to terminate 
transcription by unwinding the RNA–DNA hybrid in the RNA polymerase active site. 
The TRAMP (Trf4, Air2, Mtr4) complex then adds a short polyadenosine tail to the 3′ 
end, which is ultimately removed by the nuclear exosome.  
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Figure 1.5: Representation of telomerase RNA biogenesis in S. cervisiae. Adapted from 
[62]. S. cervisiae telomerase RNA (TLC1) is transcribed by RNA polymerase II, and the 
Nrd1-Nab3-Sen1 pathway terminates transcription. Binding of Sm proteins stabilize the 
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3’end and recruits Tgs1 which hypermethylates the cap structure. Est2 (TERT) binds 
directly to the cap structure. In addition, Ku heterodimer is required for TLC1 stability 
and nuclear import. Along with the cell cycle dependent Est1, Est3 is required for 
telomerase function at telomeres. 
Similar to small nuclear RNA (snRNA), TLC1 is bound by Sm proteins (SmB, SmD1, 
SmD2, SmD3, SmE, SmF, and SmG), which forms a heterohepatmeric ring essential for 
TLC1 stability. Additionally, Sm proteins recruit Tgs1, the methyl transferase, 
hypermethylating the cap [73]. 
Studying TLC1 trafficking has provided critical insights regarding the dynamics of RNP 
assembly and its role in telomere length regulation. Unlike humans, where TMG capping 
has been established to occur in the cytoplasm for small nuclear RNAs[60], TLC1 
hypermethylation occurs in the nucleolus [74]. During S phase, TLC1 is localized to a 
few clustered telomeres which are speculated to be elongated [75]. 	  
I.2.c: Telomerase RNA Biogenesis in Humans 
Unlike yeast and ciliate TER, human telomerase RNA (hTR) comprises of a H/ACA box 
at its 3’ end which is common feature of guide RNAs that modify snRNA and snoRNA 
[60]. In humans, H/ACA RNAs are processed from introns, which are excised from 
protein coding genes during precursor splicing [76]. In contrast, hTR is transcribed from 
its own promoter by RNA pol II. Similar to telomerase RNA in other species, mature 
hTR is non-polyadenylated and TMG capped [62, 77]. Although mature hTR is only 
451nt in length, longer polyadenylated forms have been detected but their function in 
hTR processing has remained elusive (Gaspari M & Baumann P, unpublished). The 
presence of a downstream polyadenylation signal or U1 snRNA 3′ box/transcription 
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terminator antagonizes hTR accumulation [77], leaving the actual mechanism of nascent 
transcript termination and/or endonucleolytic cleavage an open question. The importance 
of deciphering human telomerase RNA processing is highlighted by the observation that 
certain mutations in hTR, which lead to accumulation of precursor, causes dyskeratosis 
congenita in patients (Gaspari M and Baumann P, unpublished data). In other words, 
elucidating hTR processing has critical implication for DC treatment and therapy. 
Though not much progress has been made in the field of hTR processing, focusing on 
hTR dynamics has yielded fruitful results. Human telomerase RNA localizes to Cajal 
bodies via its association with TCAB1/WDR79, which recognizes a Cajal body 
localization signal in hTR called the CAB box [78]. Cellular depletion of 
TCAB1/WDR79 does not affect hTR accumulation but does reduce RNP association 
with Cajal bodies and telomeres and results in telomere shortening. Above all, the 
significance of TCAB1/WDR79 for telomere maintenance is highlighted by the discovery 
of TCAB1/WDR79 gene mutations that cause dyskeratosis congenital [59]. 
Although the different model organisms have been extremely useful in elucidating 
telomerase function in telomere repeat addition, we still know little about telomerase 
RNA biogenesis in humans. Since the small nuclear RNAs display remarkable 
conservation between S. pombe and humans, we decided to study telomerase RNA 
maturation in S. pombe. Before, we discuss this further; it is necessary to understand 
spliceosome assembly and function. 
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Figure 1.6: Schematic of human telomerase RNA biogenesis. Adapted from[62]. Human 
telomerase RNA (hTR) is transcribed by RNA polymerase II as a longer polyadenylated 
form that is inactive and is processed to mature hTR via a poorly understood processing 
mechanism. Dyskerin, NAF1, NHP2, NOP10 bind hTR and are required for its 
accumulation in vivo.  
I.3: Introduction to splicing  
Appreciation of the central role that RNA plays in controlling gene expression began 
with the advent of new methodologies and biological insights in the early 1970s and 
1980s [79]. The initial transcripts generated by RNA polymerase II are long, inactive, 
heterogeneous nuclear RNAs (hnRNAs, now termed pre-mRNAs) that are precursors for 
functional shorter mRNAs which are exported to cytoplasm for translation [80]. Seminal 
studies established that processing of adenovirus pre-mRNA to mature mRNA involves 
removal of non-coding sequences (introns) and splicing together of the coding sequences 
(exons) [81, 82]. Although splicing was initially discovered in adenovirus, we now know 
that all eukaryotes from yeast to human display this conserved mode of RNA processing. 
In case of higher eukaryotes, a diverse array of proteins is generated from the same gene 
by alternative splicing of exons [83].  Unraveling splicing at the molecular level is 
important not only for understanding gene regulation but also has a medical impetus, as 
many human diseases are caused by defective pre-mRNA splicing [84].  
Nuclear pre-mRNA splicing is catalyzed by a multi-mega dalton ribonucleoprotein 
(RNP) complex called the spliceosome. Two unique spliceosomes co-exist in most 
eukaryotes: the U2-dependent spliceosome (major) which catalyzes the removal of U2-
type introns and the less abundant U12-dependent spliceosome which is present in only a 
subset of eukaryotes and splices the rare U12-type class of introns [85]. For the 
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remainder of the introduction, I will discuss the literature on the U2-dependent 
spliceosome as this is most relevant to the thesis. 
I.3.a: Chemistry of splicing 
The spliceosome removes an intron in two consecutive reactions. In the first reaction, the 
2′ hydroxyl of a conserved, intronic adenosine attacks the phosphate at the 5′ splice site, 
producing a free 5′ exon and a branched species, termed the lariat intermediate. In the 
second reaction, the 3′ hydroxyl of the 5′ exon attacks the phosphate at the 3′ splice site, 
yielding ligated mRNA and a lariat intron [86, 87].  The intermediates and products of 
pre-mRNA splicing are similar to those generated during group II intron splicing [87]. 
I.3.b: Sequence elements required for splicing 
Three core elements namely the 5’ splice site, branch site and the 3’ splice site defines 
the intron (Fig. 1.7A). The consensus 5’ss is GUAUGU in budding yeast, GUA (A/U) 
GU in fission yeast and GURAGY in mammals [88]. The branch site consensus 
(UACUAAC) is highly conserved in budding yeast and any deviations from this site lead 
to defects in splicing. In contrast, fission yeast introns have a degenerate consensus 
branch site (CURAY), similar to mammalian introns [89]. Despite the varying length of 
introns between yeast to humans, position of the branch site seems to be under strict 
evolutionary pressure with the branch point adenosine located 18-40 nt upstream of the 
3’ss [90]. Although, increasing the distance between branch point and 3’ss impairs 
splicing, the significance of the distance constraint is not clear [91]. Apart from the 
conserved 5’ss and branch site which are necessary for the first catalytic step in all 
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eukaryotes, the polypyrimidine tract is essential for splicing in metazoans [92]. In 
contrast, a functional 3’ss is dispensable for the first catalytic step in most introns with 
certain exceptions [92, 93]. For the second step of splicing, the conserved AG 
dinucleotide is the only essential feature that is conserved in all species. The nucleotide 
preceding AG occurs in the frequency of U/C >A > G[94]. 
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Figure 1.7: Depiction of the sequence motifs required for splicing. A) The schematic 
shows the conserved motifs of 5’ss, branch site and 3’ss present in S. pombe, S. 
cerevisiae and mammalian introns respectively. (Exons- blue and red boxes and lines- 
introns; R and Y represent purines and pyrimdines respectively. B) The two steps of 
splicing are shown. Adapted from [88]. 
Additional splicing signals include short and diverse sequences called enhancers or 
silencers which are located in exons and introns. These recruit trans-acting factors to 
promote or repress splicing [90]. Although a lot of cis-elements that regulate splicing of 
an intron have been characterized, little is known about sequences that promote the first 
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step over the second. Therefore, one of the main objectives of my thesis was to 
characterize such sequences. 	  
I.3.c: Spliceosome Assembly and Rearrangement 
To compensate for the limited information present in the precursor, a large number of 
trans-acting factors that constitute the spliceosome interact with the sequences in the 
intron to spatially arrange the reactive chemical groups required for splicing in an 
optimum position. Although there are species-specific variations, the core machinery 
consists of five snRNPs namely U1,U2,U5 and U4/U6, which are conserved from yeast 
to mammals. With the exception of U6, each snRNP is composed of a snRNA that is 
transcribed by RNA pol II and a group of seven Sm proteins (B/B’,D3,D2,D1,E,F,and G) 
which are critical for snRNA stability & for modifying the cap structure of snRNA [60]. 
Surprisingly, U6 snRNA is different from the other spliceosomal snRNAs as it is 
transcribed by RNA pol II, is not TMG capped and is bound by Lsm2-8 complex [60]. 
Why U6 snRNP biogenesis is distinct from other snRNPs is not yet known. 
Since the sequence information present in the precursor is limited, the spliceosome has to 
differentiate real splice sites from decoy sites. Accuracy of splicing is ensured by 
stepwise recognition of the intron in a mutually exclusive manner. Spliceosome assembly 
begins with U1snRNP recognizing and base pairing with 5’ss. Following U1, U2snRNP 
binds to the intron by base pairing with the sequences that flank the branch point (bp) 
adenosine. However, the adenosine residue itself doesn’t base pair with U2, but instead 
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bulges out of the U2 helix, and is used as a nucleophile for the first catalytic step. After 
U2 snRNP binding, U4/U6/U5 bind the precursor RNA as a tri-snRNP. 
 
Figure 1.8: Stepwise assembly of spliceosomal snRNAs. Note that only the snRNA 
binding and transition is shown here. Adapted from [95] 
 
U4/U6 are extensively base paired, but binding of the tri-snRNP to the RNA triggers the 
release of U6 from U4. As a result, U6 displaces U1 from the 5’ ss and the spliceosome is 
said to be catalytically active for the first step. This ordered assembly of snRNPs is 
conserved from yeast to humans and prevents the spliceosome from cleaving precursor 
RNAs prematurely.  
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I.3.d: snRNAs required for catalysis 
Despite the pivotal role of U1 snRNP in early spliceosome assembly, only U2, U5 and 
U6 are required for the two catalytic steps of the spliceosome. In fact, splicing in the 
absence of U1 and U4 has been observed [96-98]. Additionally, U2 and U6 base pair 
with each other and these interactions are important for the first catalytic step. U6, which 
is at the heart of the splicing reaction, interacts with the last 3 nucleotides of most 
5’splice sites (GUAUGU), through the first 3 nucleotides of its conserved ACAGAG 
box. In contrast to the U6 and U2 binding regions, the 5’ss and branch site are poorly 
conserved among higher eukaryotes. Why this fervent anti-correlation exists between the 
spliceosomal snRNAs and its binding sites has remained elusive. 
As the chemical steps of splicing occur, the spliceosome changes its conformation from 
the first to the second step of splicing to position the reaction intermediates optimally for 
the 2nd transesterification. However, the precise nature and timing of these events is not 
completely understood. Recent data have demonstrated that base pairing of the 5’ss with 
U6 must be disrupted prior to the second step of splicing [99]. Hence, this indicates a 
requirement for U6 to shift its position after the first step, which produces a free exon and 
lariat intermediate.  Further, it has been demonstrated that the U2-branch site base pairing 
can be disrupted and is not essential for the 2nd step of splicing [100]. Whether U2-BS is 
actually detrimental to the 2nd step of splicing has not been elucidated. 
Unlike U6 and U2, U5 snRNA does not bind any sequence motif in the intron. In 
contrast, U5 plays an important role in aligning the two exons for the second catalytic 
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step. Furthermore, probing the requirements for U5 snRNA binding has revealed optimal 
sequences at the intron-exon boundaries that enhance splicing [101].Though splicing has 
been very well studied, not much is known about sequences and trans-factors required for 
the second step of splicing. After the second step of catalysis, the spliceosome releases 
the ligated RNA and lariat intron. 
I.3.e: Kinetic proofreading hypothesis 
Faithful expression of genes requires selection of cellular machineries that have high 
substrate specificity. This paradigm is inherently true for pre-mRNA splicing, where the 
spliceosome has to distinguish the real splice site from a myriad of choices [102].Since 
introns predominate over exons in eukaryotes, it is imperative to ensure splicing fidelity. 
Indeed, recent estimates of splicing errors range from 1 in 100 to 1 in 10000 [103, 104].  
Forty years ago, Hopfield and Nino proposed a model to explain how specificity is 
achieved in translation and termed it ‘kinetic proofreading’ [105, 106]. This concept has 
been validated in translation and other systems [107, 108] including splicing [109, 110]. 
A critical feature of the kinetic proofreading hypothesis is a branch in the pathway that 
competes with a productive step and specifically antagonizes suboptimal substrates. 
Christine Guthrie and colleagues extrapolated the kinetic proofreading hypothesis to 
explain the role of DExH/D ATPases in spliceosome function and splicing fidelity. From 
a genetic screen to identify splicing fidelity factors in budding yeast, Prp16 emerged as 
an ATPase that facilitates the transition of the spliceosome from the first- to the second-
step conformation [109]. Mutations in Prp16 improve the first step of splicing for 
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suboptimal substrates by lowering the rate of ATP hydrolysis by Prp16, altering its 
binding to the spliceosome, or both. Although the way in which Prp16 affects the first-to-
second step transition is not fully understood, mutations in the ATPase domain are 
thought to slow the rate of exit from the first-step conformation. Kinetic competition 
between catalysis of the first step and substrate rejection serves as the basis for the 
control of fidelity by Prp16-mediated ATP hydrolysis, also known as the kinetic-
proofreading hypothesis (Fig. 1.9). 
Since then numerous DExH/D-box ATPase/helicases have been identified that participate 
in the splicing process, and each is thought to facilitate a structural transition by coupling 
ATP hydrolysis to an interdomain movement that results in remodeled RNA-RNA and/or 
RNA-protein interactions. These structural transitions occur throughout the assembly of 
the spliceosome, the two consecutive transesterification reactions and the product release 
and disassembly phase [102]. 
 
Figure 1.9: Illustration of kinetic proof reading by various DExH box helicases at each 
step of splicing. Adapted from [111] 
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1.3.f: A ‘discard pathway’ for splicing 
Prp22 is the DExH/D box helicase that uses its ATPase activity to alter conformation of 
the spliceosome that allows release of the spliced form. Usually, the 2nd step of splicing is 
efficient and occurs before the ATP hydrolysis activity of Prp22. After exon ligation, 
Prp22 changes conformation of the spliceosome in a ATP dependent manner and releases 
the spliced form in a Prp43 dependent manner [112]. In contrast, 3’ss mutations are 
suboptimal for the 2nd step of splicing. In this scenario, Prp22 ATP hydrolysis occurs 
prior to the 2nd step of splicing, releasing the 5’ exon and lariat intermediate.  
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Figure 1.10: The discard pathway of splicing. If the rate of ATP hydrolysis by Prp22 is 
slower than the first step, then Prp22 releases ligated exons in a Prp43-dependent manner. 
However, if the rate of ATP hydrolysis by Prp22 is faster than the first step, then Prp22 
releases the intermediates, i.e. the free 5’ exon and intron lariat, in a Prp43-dependent 
manner.  
	  
	   41	  
Surprisingly, purified spliceosomes from budding yeast, in the absence of ATP no longer 
exhibit this inhibition. Similarly, Prp22 mutants that slow down ATP hydrolysis allow 
splicing of suboptimal substrates [113]. Likewise, Prp43 has been implicated in the 
discard of rejected second step intermediates [112]. In conclusion, it is evident that Prp22 
and Prp43 prevent splicing of suboptimal 3’ss using ATP hydrolysis as a timer.	  
I.3.g: Limitations of splicing studies 
The discovery that genes are not continuous but rather split by intervening sequences, 
which must  be removed by splicing was first discovered in viral mRNAs. Consequently, 
the majority of studies have focused on understanding intron removal in the context of 
protein coding genes, where release of the 5’ exon after the first step of splicing might 
lead to degradation of splicing intermediates and hinder gene expression. For this reason, 
it is not surprising that in protein coding genes, the two steps of splicing are coupled 
[114].  
I.4: Telomerase RNA biogenesis in S. pombe 
I.4.a: Spliceosomal cleavage generates mature TER1  
Telomerase RNA (TER1) in S. pombe is initially transcribed as a precursor containing an 
intron flanked by two exons [115, 116]. Similar longer forms have been identified in 
budding yeast and humans, but their function remains unclear [70, 117]. However, the 
mature form of TER1 that predominantly associates with active telomerase ends precisely 
at the 3’ end of the 5’exon. Surprisingly, functional telomerase RNA in S. pombe (TER1) 
is generated by only the first step of splicing [116]. I refer to this single step cleavage 
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event as ‘spliceosomal cleavage’. Consistent with the first step of splicing being required 
for TER1 processing, mutations in the 5’ss and branch site blocked TER1 accumulation. 
In contrast, 3’ss mutations did not alter TER1 levels. A direct role for the spliceosome in 
TER1 processing became clear when mutations in 5’ss were rescued by complementary 
changes in the U1 binding site that rescues base pairing. The idea that the second step of 
splicing is detrimental for TER1 maturation was evident when TER1 intron was replaced 
with a heterologous intron from protein coding gene, which compromised TER1 
accumulation. In contrast, mutations in the 3’ss of the heterologous intron rescued TER1 
levels. It is unknown as to how TER1 could utilize the first step of splicing but escape the 
second step for its 3’ end processing. As the TER1 intron has a very good 5’ splice site 
(ss) and branch point (bp), it undergoes an efficient first step. An unusually long distance 
of 22 nt between the branch site and 3’ss may lead to an inefficient second step. For 
example, it has been shown that increasing the distance between the branch site and the 
3’ss of the cdc2 intron leads to a significant decrease in accumulation of the spliced form 
[91]. Indeed, shortening this distance by 14 nt in the TER1 intron favors the accumulation 
of spliced form over the cleaved form and telomeres shorten. These results demonstrated 
that unlike canonical splicing, telomerase RNA maturation requires only the first step of 
splicing (Fig 1.11).   
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Figure 1.11: Representation of the difference between spliceosomal cleavage and 
canonical splicing. Canonical splicing involves tight coupling of the two 
transesterification reactions (Right). Spliceosomal cleavage generates only the first step 
of splicing followed by release of 5’ exon that forms the active telomerase complex in 
fission yeast (Left). 
I.4.2: Sm proteins and Lsm proteins are required for telomerase RNA biogenesis 
Directly upstream and partly overlapping with the spliceosomal cleavage site is a putative 
binding site for Sm proteins. Sm and like-Sm (LSm) proteins belong to an ancient family 
of RNA-binding proteins represented in all three domains of life. Members of this family 
form ring complexes on specific sets of target RNAs and have critical roles in their 
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biogenesis, function and turnover. In a manuscript that I co-authored with my colleagues 
we demonstrated that the canonical Sm ring and the Lsm2–8 complexes sequentially 
associate with fission yeast TER1 [118]. The Sm ring binds to the TER1 precursor and 
promotes the hypermethylation of the 5′-cap by Tgs1. Sm proteins are then replaced by 
the Lsm2–8 complex, which promotes the association with the catalytic subunit and 
protects the mature 3′-end of TER1 from exonucleolytic degradation. Our findings define 
the sequence of events that occur during telomerase biogenesis and characterize roles for 
Sm and Lsm complexes as well as for the methylase Tgs1. 
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Figure 1.12: Sm and Lsm proteins are required for telomerase RNA Biogenesis in S. 
pombe. (adapted from [118]). 
	  
I.5: Scope of dissertation 
The primary goal of my thesis project was to elucidate the mechanism and function of 
spliceosomal cleavage. Specifically, my aims were to determine the cis-acting elements 
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and trans-acting factors that inhibit the 2nd step of splicing. Based on these findings, I 
wanted to identify other RNAs processed by spliceosomal cleavage in fission yeast. 
 By precisely dissecting out the function of several spliceosomal components and their 
associated cis-acting elements, we have uncovered novel roles for U2 snRNP and 
U2AF59 in regulating the second step of splicing. In addition, our results invoke a critical 
role for the Prp22 and Prp43 mediated ‘discard’ pathway in TER1 biogenesis. Results of 
this aim are summarized in Chapter Three of my thesis. 
Furthermore, during the course of investigating the function of uncoupling elements 
identified in Chapter Three, we performed a global analysis of S. pombe introns to 
identify other introns that could be cleaved. Our analysis has provided new insights on 
the mechanism of splicing and indicates a possible role for the spliceosome in regulating 
gene expression. Pursuing this further, we established that 3’ end of telomerase RNA in 
other fission yeast species are also generated by spliceosomal cleavage. The significance 
and implications of these findings are presented in Chapter Four.  
Chapter Two of this dissertation consists of a comprehensive list of materials and 
methods used to execute the research described in Chapters Three and Four. Chapter Five 
provides a synthesis of the information presented in Chapters Three and Four with 
current literature. In conclusion, Chapter Five discusses the numerous future directions 
that are opened up in the field due to the core results obtained in Chapter Three and Four. 
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Chapter Two: 
Materials and Methods  
II.1: Yeast strains and constructs 
Strain 
Number 
Genotype Source 
PP138 h-  ade6-M216  leu1-32  ura4-D18  his3-D1 Lab stock 
PP265 h-   Lab stock 
PP407 h+/h- leu1-32/leu1-32  ura4-D18/ura4-D18  his3-D1/ 
his3-D1  ade6-M210/ade6-M216  ter1+/ 
ter1::kanMX6 
Box etal, 
Nature 
2008 
PP433 h+/h- leu1-32/leu1-32  ura4-D18/ura4-D18  his3-D1/ 
his3-D1  ade6-M210/ade6-M216  ter1+/ ter1::ura4 
Wen et al, 
Nature 
2011. 
PP491 h+, leu1-32, ura4, ade6-M216, rrp6::kanMX6 Lab stock 
PP550 h-, leu1-32, ura4-D18, ade6-M210 Haraguchi 
et al.; 
2007 
 
FP953 h- ade6-M216 leu1-32 ura4-D18 his3-D1, prp22::kan 
(pSH7) 
 
This study 
S. cryophilus  Lab stock 
S. octosporus  Lab stock 
 
Genotypes of the strains used in this study are listed in the table above. The basic reporter 
was generated by replacing the ura4 open reading frame in pDblet [119] with a synthetic 
DNA fragment composed of the ura4 open reading frame followed by 14 nucleotides of 
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TER1 exon 1 sequence (gggcccauuuuuug), the TER1 intron and the TER1 second exon 
using AvrII and StuI restriction sites.  Derivatives of this construct were generated by 
site-directed mutagenesis or subcloning. Plasmids were introduced into S. pombe strains 
PP138 and PP407 by electroporation and transformants were selected on Edinburgh 
Minimal Media (EMM) lacking uracil. For genomic integration, ter1::ura4 spores were 
generated from PP433 [118], germinated on YEA and selected on EMM lacking uracil.  
A DNA fragment containing the mutations in the context of a genomic copy of TER1 
was amplified from plasmid DNA by PCR using primers PBoli923 
(gtaaacggaatatccgcgatg) and BLoli1122 (ttccatatagtcgatgctcg).  The PCR product was 
purified and 1µg was used for lithium acetate transformations as described [120]. 
Transformants were selected on media containing 5’ FOA and strains containing the 
correct integration were identified by colony PCR and sequencing.   
Replacing one copy of prp22+ in a diploid strain with the kanamycin resistance marker 
generated the prp22 knockout strain.  The heterozygous prp22+ / prp22::kanR strain was 
transformed with plasmid pSH3 containing wild type prp22+ and the ura4 gene. The 
diploid transformants were sporulated and prp22::kanR cells containing pSH3 were 
selected. The resultant strain was then transformed with a plasmid derived from pBG1 
[121] containing prp22+ or point mutants and the his3 gene as a selection marker. Media 
containing 5-fluoroorotic acid and lacking histidine was used to select for cells that have 
lost pSH3 and now harbor a prp22 mutant or prp22+ on the pBG1-derived plasmid. The 
presence of each prp22 mutant allele was confirmed by PCR and sequencing. 
Temperature and cold sensitivity were examined by incubation at 36°C and 22°C 
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respectively. The same procedure was employed to generate temperature sensitive prp43 
strains which contained prp43 mutants on a plasmid derived from pBG1 in a prp43::kanR 
background. 
II.2: RNA analysis 
Cultures (400 ml) were grown to a density of 5 x 106 cells/ml and cells were collected by 
centrifugation in JA 10 rotor (Beckmann) for 4 min at 4000g [116]. Cell pellets were 
washed once with cold water and quick frozen as beads by dripping into liquid nitrogen. 
Cells were lysed in a 6850 Freezer mill (SPEX SamplePrep) using 8 cycles (2  min) at a 
rate of 10 per second with 2  min cooling time between cycles. After grinding, the lysed 
powder was transferred into 50 ml falcon tubes containing 10 ml of 
phenol/chloroform/isoamyl alcohol (25:24:1) and 10  ml sodium acetate (50  mM), 1% 
(w/v) sodium dodecyl sulphate preheated to 65  °C. The purity of RNA was increased by 
extracting RNA at least 5 times with phenol/chloroform/isoamyl alcohol and once with 
and once with chloroform/isoamyl alcohol. The supernatant containing RNA was 
subjected to ethanol precipitation and resuspended in 50 mM Sodium Acetate (pH 5.2) 
The following modifications were made for temperature sensitive strains. Cultures (400 
ml) of U2AF59 ts strains were grown at 25°C to a density of 5 x 106 cells / ml.  The 
culture was shifted rapidly to 36°C by immersion and agitation in warm water. Once the 
culture medium had reached 36°C, a 100 ml sample was taken for RNA isolation. 
Cultures were then transferred into a shaker at 36°C and additional samples were 
harvested at the indicated time points.  Similarly, prp22 and  prp43 mutant strains were 
grown into log phase at 32°C and shifted rapidly to 22°C. The point at which the culture 
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medium reached 22°C is referred to as 0 minute. To isolate RNA, 3 or 5 rounds of phenol 
chloroform extraction were performed depending on whether the sample volume was 100 
ml or 400 ml. After the final chloroform isoamyl alcohol extraction, the supernatant 
containing RNA was ethanol precipitated at -20°C for at least one hour. Total RNA was 
precipitated by centrifugation and the pellet was dissolved in 50 mM sodium acetate at 
pH 5.2. Except for the northern shown in Fig. 3.1B, all samples were subjected to 
RNaseH cleavage prior to northern analysis to improve resolution of precursor, spliced 
and cleaved forms.  Briefly, 15 µg of DNase treated RNA were combined with two DNA 
oligos (600 pmol) complementary to sites in the first and second exon, respectively. 
BLoli2269 (AACATCCAAGCCGATACCAG) and BLoli2326 
(GCAAACAAGGCATCGACTTTTTCAATAACCAACCAAAA) were used for 
constructs containing the ORF and 3’ UTR of ura4. BLoli2326 was replaced with 
BLoli1275 (CGGAAACGGAATTCAGCATGT) for constructs containing TER1 
sequences downstream of the intron. Oligonucleotides BLoli3695 
(TGGGCAATTGTATTCTCTGC), BLoli3563 (AAAAGCCAACGTAAATGCTG) and 
oligo-dT were used for RNaseH cleavage of ATP23 mRNA. The mix was heated to 65°C 
in a heat block and a second heat block at 75°C was placed on top of the tubes to reduce 
condensation. After 5 min, the heat block sandwich was transferred to a Styrofoam box to 
allow slow cooling to room temperature. After 45 min of slow cooling, RNaseH buffer 
(NEB, final concentration 1 X) and RNaseH enzyme (5 units) were added and samples 
were incubated at 37°C for 30 min. RNaseH treated samples were ethanol precipitated for 
at least one hour at -20°C. RNA pellets were recovered by centrifugation, dissolved in 1X 
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formamide loading buffer and run on a polyacrylamide gel for northern analysis as 
described below.  
	  
II.3: Northern Blot 
Samples were run on 4% polyacrylamide gels in Tris-borate-EDTA (TBE) containing 7M 
Urea and transferred to a Biodyne Nylon transfer membrane (Pall Corporation) in TBE 
buffer at 0.4  A for 1  h in 0.5× TBE buffer. RNA was ultraviolet cross-linked (254  nm, 
120  mJ) in a Stratalinker (Stratagene). Hybridizations with radiolabelled probes were 
carried out in Church-Gilbert buffer at 55  °C (TER1 probe) or 42  °C (reporter and sn101 
probes). A TER1 probe recognizing the RNaseH cleavage products was generated by 
nick-translation of a PCR fragment (nucleotides 536 to 998 of TER1) in the presence of 
32P-α-dCTP. The ura4 open reading frame was detected using BLoli2072 
(GTCTTTGCTGATATGCCTTCCAACCAGCTTC) and the 3’ UTR with BLoli2318 
(GAAACCGGAAACGGAATTCAGCATGTTTTAATAAAAAGAT), each labeled with 
polynucleotide kinase in the presence of 32P-γ-ATP. BLoli1136 
(CGCTATTGTATGGGGCCTTTAGATTCTTA) complementary to snRNA101 was 
used to visualize a loading control.  ATP23 mRNA was detected on northern blots using 
a nick-translated PCR fragment generated with primers BLoli3693) and BLoli3592 
(AGGAATTGAACACTTCTTCAACGAT) as probe and a hybridization temperature of 
55 °C. 
 
II.4: RT–PCR 
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DNase-treated RNA samples (2.5  µg) were incubated with oligonucleotide BLoli1275 
(CGGAAACGGAATTCAGCATGT, 10  pmol) and dNTP mix (10  nmol). The total 
volume was adjusted to 13  µl with distilled water and samples were heated to 65  °C for 
5  min and allowed to reach room temperature by slow cooling. The volume was increased 
to 20  µl by the addition of RNasin (40  U, Promega), dithiothreitol (5  mM final), 5× first 
strand buffer, and Superscript III reverse transcriptase (200  U, Invitrogen). Control 
reactions did not include SuperscriptIII to monitor for DNA contamination. After 
incubation at 55  °C for 60  min, RNaseH (5  U, NEB) was added and incubation was 
continued at 37  °C for 20  min. Aliquots (2  µl) of the RT reactions were used for PCR 
amplification with Taq polymerase (NEB) and oligonucleotide primers BLoli1020 
(CAAACAATAATGAACGTCCTG) and BLoli1275 under the following conditions: 
5  min at 94  °C followed by 30  cycles of 30  s at 94  °C, 30  s at 57  °C and 60  s at 72  °C, 
followed by 10  min at 72  °C. PCR products were analysed by electrophoresis on 1.8% 
agarose gels. For splicing analysis of FCP1 intron1, Bloli 2149 
(ATTGAAATCGCGAGCTGTCT) and Bloli 2150 (TTCCACAAATTGCACAGAGG) 
were used. 
II.5: Determination of 3’ end sequences  
DNase-treated total RNA samples (2.5 mg) were treated with poly (A) polymerase (US 
Biologicals), RNase inhibitor (RNasin, 40 U), and ATP (0.5 mM) in the buffer provided 
by the manufacturer in 20 µl reactions and incubated at 30 °C for 30 min. The reaction 
volume was increased to 35.5 µl by the addition of the DNA oligonucleotide PBoli560 
(GCGGAATTCT18, 125 pmol), dNTP mix (25 nmol), and the reactions were incubated 
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at 65 °C for 3 min followed by slow cooling to room temperature (20 °C). The reaction 
volume was then adjusted to 50 ml with first strand buffer (Invitrogen), dithiothreitol (5 
mM), RNasin (40 U) and Superscript III reverse transcriptase (200 U, Invitrogen), and 
reactions were incubated at 50 °C for 60 min. This was followed by addition of RNaseH 
(5 U, NEB) and incubation was continued at 37 °C for 20 min. Aliquots (2.5 ml) of this 
reaction were used for PCR amplification with Taq polymerase (5 U, NEB), and 
oligonucleotide PBoli517 (GCTTTTGGCTGAAATGTCTTCC) specific for ura4 and 
PBoli560 (200 nM each) under the following conditions: 3 min at 94 °C followed by 30 
cycles of 30 s at 94 °C, 45 s at 55 °C and 120 s at 72 °C, followed by 7 min at 72 °C. 
PCR products were separated by electrophoresis on 0.8% agarose gels, and bands of the 
correct size were excised, purified and cloned into the TOPO TA cloning system 
(Invitrogen) for sequence analysis.  
II.6: Spotting Assay 
Cultures were grown to log phase (5x106 cells/ml) in EMM supplemented with uracil 
(150 mg/L), leucine (150 mg/L), and adenine (75 mg/L). 3-fold dilutions of samples were 
plated on PMG (Pombe Minimal media with Glutamate) in triplicate using an epMotion 
automated pipetting system (Eppendorf) and plates were incubated at 22°C, 32°C and 
36°C, respectively. Plates were scanned after 3 days at 32°C and 36°C and after 7 days at 
22°C. 
II.7: Computational analysis 
To create a database of S. pombe introns we first compiled the sequences 
corresponding to the 4862 introns based on a 2007 release of the S. pombe genome. The 
	   53	  
sequence corresponding to the TER1 intron was added manually. We then applied a filter 
to remove duplicate sequences and annotated introns that did not begin with ‘GT/C’ and 
end with ‘AG’, which reduced the number to 4824 putative intronic sequences. 
A Gibb’s sampler (http://bayesweb.wadsworth.org/gibbs/gibbs.html) was then 
used to construct position weight matrixes (PWM). The first 7 and last 3 nucleotides were 
excluded as they represent the 5’ and 3’ splice sites, respectively. The recursive sampling 
algorithm was used with the default settings for eukaryotes. The top 5 motifs of lengths 7, 
9, and 10 were evaluated. All PWMs generated by this analysis resembled branch sites. 
The Gibb’s sampler was rerun to construct the best PWM found at least once in all of the 
sequences.  The final branch site PWM (represented as a sequence logo in Fig. 5.1A) was 
10 nucleotides long. 
BS scores were calculated as follows. At each position a BS score SBS was 
calculated by applying equation 1 to a 10-nucleotide window starting at that position. In 
this equation fi  is the frequency for the nucleotide found in the PWM at position i , and 
Ii  is the Shannon-information (in bits) for position i  as calculated from the PWM for 
that position (the Shannon-information was calculated as described [122]. The score SBS 
is therefore the total number of bits for the sequence contained in the window as defined 
by the branch site PWM. Using this scoring method the top scoring sequence is 
‘TTACTAACTT’ which has a SBS = 7.856. . 
Equation 1:              SBS = fi Ii
i=1
10
∑  
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The average SBS for all positions was 3.1, but the average score for the highest 
scoring position in each intron was 7.1 (Fig. 5.2D).  Approximately 96% of all introns 
had at least one site with a score >6 (Fig. 5.2C), this was therefore used as the cutoff for 
predicting putative branch sites in each intron. Nearly half (42%) of the introns had only 
a single site with a score >6 (Fig. 5.2D). In the cases where there was more than 1 site 
with a score >6 the site that was closest to the acceptor site, but was greater than 5 
nucleotides from the 3’ ss, was chosen as the putative BS.  
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Chapter Three: 
Intronic sequence elements impede exon ligation and trigger a discard 
pathway that yields functional telomerase RNA in fission yeast 
	  
III.1: Abstract 
The fission yeast telomerase RNA (TER1) precursor harbors an intron immediately 
downstream of its mature 3’ end. Unlike most introns, which are removed from precursor 
RNAs by the spliceosome in two sequential but tightly coupled transesterification 
reactions, TER1 only undergoes the first cleavage reaction during telomerase RNA 
maturation.  The mechanism underlying spliceosome-mediated 3’ end processing has 
remained unclear. We now demonstrate that a strong branch site (BS), a long distance to 
the 3’ splice site (3’ ss) and a weak polypyrimidine (Py) tract act synergistically to 
attenuate the transition from the first to second step of splicing. The observation that a 
strong BS antagonizes the second step of splicing in the context of TER1 suggests that 
the BS – U2 snRNA interaction is disrupted after the first step and thus much earlier than 
previously thought. The slow transition from first to second step triggers the prp22 DExD 
box helicase dependent rejection of the cleaved products and prp43 dependent ‘discard’ 
of the splicing intermediates. Our findings explain how the spliceosome can function in 
3’ end processing and provide new insights into the mechanism of splicing.  
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 III.2: Introduction 
The enzyme telomerase replenishes repetitive DNA sequences at the ends of eukaryotic 
chromosomes that otherwise shorten with each round of replication [123].  At its core, 
telomerase is comprised of a catalytic protein subunit and a non-coding RNA component. 
The RNA serves as a scaffold for the assembly of the holo-enzyme and provides the 
template for telomeric repeat synthesis by the catalytic subunit telomerase reverse 
transcriptase (TERT).  
The gene encoding the telomerase RNA subunit from the fission yeast 
Schizosaccharomyces pombe has been identified [115, 124] and examination of the 
maturation pathway revealed that the RNA is first transcribed as a longer poly-adenylated 
precursor containing an intron immediately downstream of the 3’ end of the mature form 
[116]. Interestingly, the mature 3’ end of TER1 is generated by a single cleavage reaction 
at the 5’ splice site akin to the first step of splicing (Fig 5.1A).   
Prior to cleavage, a ring of seven Sm proteins binds the TER1 precursor directly 
upstream of the intron and recruits the methylase Tgs1, which converts the monomethyl 
guanosine cap at the 5’ end of TER1 into the trimethyl guanosine form [118]. After 
cleavage by the spliceosome has occurred, Sm proteins dissociate from the RNA and are 
replaced by a related protein complex comprised of seven Like-Sm proteins, Lsm2 to 8 
[125]. The Lsm complex protects the 3’ end of telomerase RNA against degradation and 
promotes assembly of the RNA with the catalytic subunit of telomerase [118]. The 
identification of several key events that convert the telomerase RNA precursor into the 
mature form has laid the foundation for mechanistic studies.  A question of particular 
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interest is how the spliceosome carries out a single cleavage reaction in 3’ end processing 
when its normal role is to remove introns in two tightly coupled steps?  
In the first step of intron excision, the 2′ hydroxyl of the branch point (BP) adenosine, 
located within the branch site (BS) sequence, attacks the sugar-phosphate bond at the 5′ 
splice site (5’ ss), forming a 2’-5’ linkage and producing a free 5′ exon and a branched 
species, termed the lariat intermediate [114].  In the second reaction, the now exposed 3′ 
hydroxyl of the upstream exon attacks the phosphate at the 3′ splice site (3’ ss), yielding 
ligated mRNA and the lariat form of the intron.  Although the TER1 intron contains all 
RNA elements required for complete splicing, the level of spliced TER1 accounts for less 
than 1% of TER1 isoforms in actively growing cells [116].   
Consistent with telomerase RNA 3’ end processing involving only the first step of 
splicing, nucleotide changes at the 5’ ss and the BP adenosine blocked TER1 maturation 
[116]. In contrast, mutations at the 3’ ss did not impair the accumulation of the cleaved 
form, but eliminated the small amount of spliced TER1 that is normally observed [116]. 
Direct evidence for spliceosome-mediated 3’ end processing of TER1 came from 
experiments in which 5’ ss mutations were rescued by compensatory changes in the U1 
snRNA which base pairs with the 5’ ss during spliceosome assembly. Furthermore, 
replacement of the TER1 intron with a heterologous intron from a protein-encoding gene 
resulted in the production of spliced TER1 RNA, which failed to support telomerase 
activity. When the 3’ ss was mutated in this context, some cleaved TER1 was produced 
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and telomere maintenance was partially restored [116]. Blocking the completion of 
splicing is thus of pivotal importance for producing functional telomerase enzyme. 
The mechanism of splicing has been studied primarily in the context of protein encoding 
genes. There, release of the 5’ exon after the first cleavage reaction would block gene 
expression as released splicing intermediates will be degraded rather than translated. It is 
thus no surprise that the two steps of splicing are tightly coupled, and at least for some 
introns the first step of splicing is dependent on the presence of an intact 3’ ss [91, 92, 
126]. It is presently unclear whether fission yeast telomerase RNA is unique in utilizing 
the first step of splicing for 3’ end processing or whether it is the first example of a class 
of non-coding RNAs that are processed in this manner.  The observation that introns are 
found near the 3’ ends of telomerase RNAs from several other fungi indicates that 
spliceosomal 3’ end processing is at least not limited to S. pombe [127, 128], P.B., 
unpublished data).  
Here we show that the ability of the spliceosome to function in 3’ end processing is 
intrinsic to the kinetic quality control mechanism that permits discard of suboptimal 
intermediates [112, 113, 126, 129].  The uncoupling of the first and second step of 
splicing that occurs naturally in the context of TER1 processing provides new insights 
into the roles of the branch site in splicing.  
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III.3: Results 
III.3.a: RNA elements within the intron inhibit the second step of splicing.  
Many RNA processing events are initiated by the recruitment of processing factors to the 
carboxy-terminal domain (CTD) of RNA pol II [130-132]. These factors travel with the 
polymerase during transcription and act on the nascent RNA transcript upon recognition 
of a processing signal [133]. To test if the ter1 promoter and first exon are required for 3’ 
end processing by the spliceosome, we replaced them with the promoter and open reading 
frame of the ura4 gene. As the binding of Sm proteins directly upstream of the 5’ splice 
site may be responsible for inhibiting the completion of splicing, 14 nucleotides of TER1 
sequence including the Sm site were included in the chimeric construct.   A radiolabelled 
oligonucleotide probe complementary to TER1 exon 2 was used to detect the precursor 
and spliced forms (Fig. 3.1B, upper panel).  Reprobing the northern with a probe 
complementary to the first exon (Ura4 ORF) revealed an additional faster migrating form 
corresponding in size to the first exon, the expected product of the first step of splicing 
(middle panel).  This form was insensitive to a mutation of the 3’ ss (lane 4), but was 
abolished when the 5’ ss was mutated (lane 5).  Its identity as the product of spliceosomal 
cleavage was further confirmed by cloning and sequencing its 3’ terminus (Fig. 3.2) 
Consistent with previous findings in the context of endogenous TER1 [116], reducing the 
distance between the BP and 3’ ss to nine nucleotides promoted complete splicing (Fig. 
3.1, lane 6).   
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Figure 3.1: The TER1 intron contains all elements required for spliceosomal cleavage. 
(A) Schematic of TER1 3’ end processing by the first step of splicing. The branch site 
(BS) is shown as a circle and poly(A) tails are indicated by dashed lines. (B) Northern 
blot on RNA isolated from cells expressing reporter constructs as indicated. Ura4 
sequence is shown in blue, TER1 sequence in green; mutations at the 5’ ss and 3’ ss are 
symbolized by red crosses. A 32P-labeled oligonucleotide complementary to the second 
exon (position indicated by purple line above lane 3) was used for detection of precursor 
and spliced forms (top panel). The northern was reprobed with a radiolabeled oligo 
complementary to the first exon to also visualize the cleaved form (middle panel, position 
of probe is indicated by red line above lane 3).  A probe against snoRNA snR101 was 
used as loading control (LC). (C) Schematic of RNaseH cleavage assay. Cleavage sites 
are indicated by clusters of vertical arrows. Those cleavage products that are homogenous 
in size and visualized on northern blots are underlined. The probe used for detection of all 
three forms is indicated by a red line.  (D) RNaseH cleavage followed by northern blot 
analysis of the indicated constructs. TER1 sequences in green, URA4 sequences in blue, 
a red arrow points to the cleaved form. Products were detected using a probe 
complementary to the first exon as indicated in (C). The ratios of cleaved form to LC for 
each lane were normalized to wild type (lane1) with the data being represented as mean 
+/- SEM from three independent experiments. (E) As in (D) for additional constructs 
including one that places the TER1 intron in an entirely heterologous context (lane 4). 
Differences in mobility for each form between lanes reflect differences in the length and 
sequence of constructs used. Quantification as described in (E) with n=2. 
 
The similarity in sizes and length heterogeneity arising from multiple poly-adenylation 
sites and variable polyA tail length complicated quantification of the different RNA 
forms on northern blots. This issue was resolved by treating the RNA with RNaseH in the 
presence of two DNA oligonucleotides complementary to sites in exons one and two, 
respectively (Fig. 3.1C). Following RNaseH cleavage, precursor, spliced and cleaved 
forms resolved into three well-separated bands (Fig. 3.1D, lane 1).  A 2.3 fold increase in 
the cleaved product was observed when the second step of splicing was blocked by a 3’ 
ss mutation (lane 2).  A 5’ ss mutation reduced the first step by more than 10-fold (lane 3) 
and shortening the BP to 3’ ss distance promoted complete splicing (lane 4).   
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Figure 3.2: Cloning and sequencing of 3’ end processing products.  (A) Schematic of 
protocol used to capture the 3’ ends of the spliceosomal cleavage products. RNA (shown 
in blue) was tailed by treatment with poly (A) polymerase in the presence of ATP and 
reverse transcribed using an oligo-dT primer. The first-strand cDNA (shown in red) was 
amplified by polymerase chain reaction (PCR) using oligo-dT and the gene specific 
primer (PBoli517; GCTTTTGGCTGAAATGTCTTCC). (B) The PCR products of 3’ end 
cloning reaction were separated by agarose gel electrophoresis and visualized using 
ethidium bromide staining. The appearance of a band corresponding to the first exon 
released after spliceosomal cleavage is dependent on the reporter undergoing 
spliceosomal cleavage rather that complete splicing and on PAP treatment. The second 
exon of TER1 is shown in green, URA4 sequences in blue, the TER1 intron as a black 
line and the branch site as a red circle. The construct used in lane 3 has a shortened 
distance between the BP and 3’ss and is thus efficiently spliced. Poly (A) polymerase was 
omitted from the samples in lanes 3 to 6. As the cleaved form is not polyadenylated in 
vivo, the lowest band is absent in these lanes. (C) Six representative sequences 
corresponding to the fast migrating band in lane 1 in (B). The URA4 reporter sequence 
ends precisely upstream of the 5’ splice site (indicated by arrow) confirming the identity 
of this band as the product of spliceosomal cleavage. The run of adenosines reflects 
nucleotides added by PAP. 
 
The observed cleavage of a reporter containing a heterologous promoter and first exon 
indicated that the TER1 Sm site, intron and second exon contain all elements required to 
inhibit the second step of splicing.  To further define the essential elements, we deleted 
the Sm site (Fig. 3.1E, lane 3) and replaced the TER1 second exon with the 3’UTR of 
ura4 (lane 4), neither of which reduced the levels of cleaved form.  The spliced form was 
more abundant in the context of the ura4 3’UTR than in the presence of the TER1 second 
exon.  This may reflect differences in stability between the two products or a context 
dependency of splicing efficiency.  In either case, these results show that the TER1 intron 
is sufficient to promote spliceosomal cleavage of a heterologous RNA and thus harbors 
the elements required to uncouple the two transesterification reactions.  
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III.3.b: The strength and spacing of the 3’ intronic elements control uncoupling. 
Since deletion of 14 nucleotides between the BP and 3’ ss promoted complete splicing, 
we asked whether inhibition of the second step of splicing was due to the long distance or 
a specific sequence motif. Starting with the ter1-55 mutant (Fig. 3.3A) we increased the 
distance between the BP and 3’ ss in a step-wise manner by insertion of adenines. 
Adenines were chosen as increasing pyrimidine content between the BP and 3’ ss has 
been shown to promote splicing in fission yeast [91] and metazoans [92].  As the BP to 3’ 
ss distance was increased from nine to 12 and 16 nucleotides, we observed a stepwise 
increase in the cleaved form (Fig. 3.3B).  However, the spliced product was also readily 
detected by northern blot for all three constructs and dominated over the precursor in RT-
PCR analysis (Fig. 3.3C). Further increasing the distance from 16 to 20 nucleotides 
resulted in an 8-fold increase in the cleaved product, indicating that the second step of 
splicing was specifically inhibited by the increased distance between BP and 3’ ss.  The 
first step appeared unaffected by the replacement of endogenous TER1 sequence with 
adenosines as the 9+11A and 9+14A constructs yielded as much or more cleaved product 
as wild type TER1 (Fig. 3.3B, compare lanes 1 with 4 and 5).   
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Figure 3.3: A long distance between the BP and 3’ ss inhibits the 2nd step of splicing. (A) 
Intronic sequences of TER1 constructs used in (B) and (C). Splice and branch sites are in 
capital letters for emphasis. Inserted adenosines are underlined. (B) Northern blot 
analysis for ter1 constructs expressed from plasmids under the control of the ter1 
promoter. RNaseH cleavage was used to improve resolution of precursor, spliced and 
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cleaved forms. The cleaved form was quantified relative to loading control snRNA101 
(LC) and normalized to wild type levels. The data were represented as mean +/- SEM 
with n= 2 for ‘9+3A’ construct and n=3 for all other constructs. An arrow points to the 
cleaved form. (C) RT-PCR across the TER1 intron to visualize the relative abundance of 
precursor and spliced forms. 
 
The observation that the first step but not the second step of splicing proceeded 
efficiently in the 9+14A mutant was surprising as the replacement of endogenous TER1 
sequence with 14 adenosines eliminated the Py-tract.  Biochemical analysis in fission 
yeast cell-free extracts has identified the Py-tract as an important element in spliceosome 
assembly at a step preceding U2 recruitment [134]. In humans, Py-tract strength 
predominantly affects spliceosome assembly and efficiency of the first step [92, 135], but 
effects of distance and sequence on the second step have been observed as well [92, 136, 
137]. To further investigate the effect of pyrimidine content in the context of telomerase 
RNA 3’ end processing, additional constructs with weak and strong Py-tracts were 
synthesized and integrated at the TER1 locus (Fig. 3.4A). TER1 itself has a moderately 
 
strong Py-tract with an uninterrupted run of five pyrimidines and an overall pyrimidine 
content of 65% between the BS and 3’ ss. Increasing the pyrimidine content favored 
completion of the second step as indicated by a 2-fold reduction in the cleaved form and 
now readily detectable levels of fully spliced product for the Py+ construct (Fig. 3.4B).  
In contrast, loss of the Py-tract in the context of the TER1 intron had little effect on the 
first or second step of splicing (lane 3).   
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III.3.c: A role for U2AF in promoting the second step of splicing. 
During spliceosome assembly the Py-tract is bound by the large subunit of U2AF 
(U2AF65 in mammals, U2AF59 in fission yeast; [138-140]. Py-tract strength correlates 
with U2AF65 binding affinity and selection experiments have shown that U2AF65 
prefers binding sites containing uridines over cytosines [141]. Replacement of the five 
cytosines in the TER1 Py-tract with uridines (C2U mutant) resulted in an increase in 
spliced form at the expense of first step product (Fig. 3.4B, lane 4). This result further 
supports that a strong Py-tract favors completion of splicing and indicates that the effect 
may be mediated by U2AF. We thus examined processing of the TER reporter construct 
in the context of a temperature sensitive allele of U2AF59 [142]. When RNA was 
isolated from cells immediately after shifting to the restrictive temperature, a 2.5-fold 
lower level of cleaved TER1 was observed in U2AF59ts compared to wild type cells (Fig. 
3.4C). This is consistent with a modest assembly and first step defect even at the 
permissive temperature.  Interestingly, no further reduction in the first-step product was 
observed in the mutant after 30 minutes at the restrictive temperature.  However, the 
second step of splicing was now impaired as evidenced by a 2-fold reduction in the level 
of spliced form in the mutant.  Taken together, these observations reveal that in the 
context of the TER1 intron the first step of splicing occurs largely independent of the 
presence of a Py-tract.  Notably though, completion of the second step of TER1 splicing 
was favored by a strong Py-tract and functional U2AF59.  
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Figure 3.4: A strong Py-tract and U2AF59 favor completion of the 2nd step of splicing. 
(A) TER1 mutants with strengthened (Py+) or weakened (Py-) pyrimidine tract or 
cytosines replaced with uridines (C2U) were integrated at the ter1 locus.  (B) Detection 
of precursor, spliced and cleaved forms by northern blot. LC and quantification as in 2B 
with n=2. (C) Northern analysis of RNA from cells containing the ura4 reporter with 
TER1 intron in the context of prp2+ (U2AF59) and prp2D307N mutant, respectively. Cells 
were grown at 25°C to 5 x 106 cells/ml, shifted to 36°C and harvested after 0 or 30 min. 
Quantification of cleaved and spliced forms relative to LC (snR101) for each lane and 
normalized to wild type (lane 1). Quantification were performed as in Fig. 2B with n=2. 
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III.3.d: Unexpected role for the branch site in inhibiting completion of splicing. 
Although the BP to 3’ ss distance is about twice as long in the TER1 intron than the 
median distance for all annotated introns in the S. pombe genome (see below), well over 
100 introns in protein encoding genes have a similar or greater BP to 3’ ss distance.  We 
thus wondered whether these introns are efficiently spliced. The first intron in the fcp1 
gene encoding for a serine phosphatase [143] resembles the TER1 intron in overall length 
and architecture with a BP to 3’ ss distance of 24 nucleotides (Fig. 3.6A, B).  However, 
when this intron was inserted into the reporter robust completion of splicing was 
observed (Fig. 3.5A, lane 2).  The intron was also efficiently spliced in the context of the 
endogenous fcp1 gene (Fig. 3.6C).  A longer distance between BP and 3’ ss is therefore 
not sufficient to account for the uncoupling of the first and second step of splicing in 
TER1. 
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Figure 3.5: A strong BS inhibits the second step of splicing. (A) Northern blot analysis 
of reporter constructs that contain the TER1 intron (green) or FCP1 intron (pink) between 
ura4 ORF and 3’ UTR (blue). Chimeric reporters contain TER1 or FCP1 BS indicated by 
green or pink filled circles, respectively. A probe against snR101 was used as loading 
control (LC) for normalization of cleaved form relative to lane 1 with the data being 
represented as mean +/- SEM (n=2). (B) Schematic of base pair interactions between U2 
snRNA and branch sites of FCP1 and variations including the TER1 BS sequence. A 
vertical line is used to represent Watson Crick base pairing, two dots represent G:U 
interactions. The bulged adenosine at the branch point is drawn above the paired 
sequence. Nucleotide changes from the wild type FCP1 sequence are highlighted in 
green. (C) Northern blot analysis for reporter constructs with FCP1 intron containing the 
indicated branch site sequences. Quantification as in (A) with n=2 for UAUUAAC, 
AACUAAC mutants and n=3 for other mutants. (D) Distance between BP and 3’ ss was 
varied in the context of the FCP1 intron with a strong BS (for schematic see SF 2E). The 
cleaved forms were quantified relative to loading control (LC) and normalized to lane 1 
(n=2). 
 
To identify sequence elements responsible for spliceosomal cleavage several chimeric 
introns were generated and tested in the context of the reporter assay.  Chimeras 
containing TER1 sequences upstream of the branch site and FCP1-derived sequences 
between the BS and 3’ ss were spliced well, whereas reciprocal chimeras were processed 
poorly (Fig. 3.5A and Fig. 3.6D).  Most notable, in otherwise identical constructs, 
spliceosomal cleavage was observed when the BS sequence was derived from TER1, but 
not with the BS sequence from FCP1 (Fig. 3.5A, lanes 3 and 4 and Fig. 3.6D).  This 
observation was surprising, as cross-linking between U2 and the BS in the pre-mRNA 
and in the excised intron lariat had led to the view that the U2 – BS association is 
maintained through both steps of splicing [144].  In contrast, our observation suggests 
that a tight U2 – BS interaction promotes accumulation of the 5’ cleavage product, 
although in the context of the reporter the spliced form still predominates.   
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The TER1 branch site is fully complementary to the BS binding sequence in U2 snRNA 
(Fig. 3.5B), whereas the BS in FCP1 intron 1 deviates by two nucleotides from the U2 
complement, resulting in a mismatch and the replacement of a G-C base pair with a G:U 
wobble (Fig. 3.5B).  These two nucleotide differences alone reduced the level of cleavage 
product by 10-fold (Fig. 3.5C).  Restoring one or the other of the Watson-Crick base pairs 
resulted in spliceosomal cleavage at 16 and 27% of the level observed with the TER1 
intron, respectively (lanes 3 and 4).  When both nucleotides were changed together, 
spliceosomal cleavage products accumulated to 56% of the TER1 control (lane 5).  
Further increasing the distance between BS and 3’ ss to 38 nucleotides stimulated 
spliceosomal cleavage at the expense of splicing, whereas reducing the distance promoted 
the 2nd step of splicing (Fig. 3.5D).      
These observations demonstrate that, at least in the context examined here, the U2 – BS 
interaction has opposing effects on the first and second step of splicing.  High U2 
complementarity promotes spliceosome assembly and the first cleavage reaction, but is 
inhibitory to the completion of splicing.  The most parsimonious explanation for these 
findings is that U2 must  dissociate at least partially from the BS for splicing to proceed 
beyond the first step.  
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Figure 3.6: Chimeric introns identify the branch site as a key determinant for the 
inhibition of the second step of splicing. (A) Schematic of fcp1 gene structure comprised 
of 6 exons (rectangles) and 5 introns (lines). Introns are numbered and arrows mark the 
positions of primers used to examine the efficiency of splicing for intron 1.  (B) 
Comparison of intronic sequences and distances for TER1 (black) and FCP1 intron 1 
(pink).  The 5’ and 3’ splice sites and the branch site (BS) are underlined and capitalized. 
(C) RT-PCR across FCP1 intron1 using primers BLoli2149 
(ATTGAAATCGCGAGCTGTCT) and BLoli2150 (TTCCACAAATTGCACAGAG). 
RT=reverse transcriptase was omitted from the control reaction.  (D) Northern blot 
analysis for reporter constructs containing the ura4 ORF and 3’UTR (blue), and chimeric 
introns (TER1 sequence in green, FCP1 sequence in pink). Branch sites are depicted by 
circles filed in green or pink depending on the origin of the BS sequence.  (E) Partial 
sequence of constructs used in Figure 4D.  Mutations in the BS sequence that convert 
the FCP1 BS into the TER1 BS are shown in green. An insertion of 12 adenosines 
increases the BP to 3’ss distance to 38 nucleotides, whereas a deletion of 15 
nucleotides reduces the distance to 9 nucleotides. 
III.3.e: The ‘discard’ pathway promotes spliceosomal cleavage.  
The transition from the first to the second step of splicing involves major conformational 
changes within the spliceosome. Biochemical experiments using budding yeast cell-free 
extracts have revealed a quality control mechanism that monitors the success of exon 
ligation [112, 113].  When the DExD box helicase Prp22 hydrolyses ATP prior to the 
exon ligation step, the splicing intermediates are rejected.  This process has been 
suggested to permit recycling of spliceosomes bound to mutant RNA substrates that arise 
due to RNA polymerase errors or mutations in the DNA template [102]. It also allows 
recovery of spliceosomes that have selected suboptimal 3’ splice sites.  
Here we have identified several elements in the TER1 intron that encumber the first to 
second step transition and may thus trigger Prp22-dependent ‘discard’ of the first-step 
products.  Based on sequence similarity with S. cerevisiae PRP22 and other DExD-box 
helicases [145], we designed point mutations in S. pombe prp22. T665A and H634A 
displayed weak temperature sensitivity, whereas S663A was strongly cold sensitive (Fig. 
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3.8A). As prp22 promotes the release of first and second step products in an ATPase-
dependent manner and also stabilize the exon ligation conformation in an ATPase-
independent manner, it was important to distinguish between these effects. Mutations that 
affect the ATPase activity and thereby impair ‘rejection’ are expected to permit increased 
completion of splicing, whereas mutations that compromise the prp22 function in exon 
ligation will reduce the amount of spliced product. We therefore calculated what fraction 
of RNA had undergone the first and second step respectively and normalized to the wild 
type sample at 32 °C, for which both values were set to 100.  Although such 
quantification does not directly measure the actual percentage of RNA molecules that are 
released after the first step, it is nevertheless an established measure for first and second 
step efficiencies [99].  All three mutations in the Prp22 helicase domain shifted the ratio 
of first to second step product in favor of spliced RNA supporting a role for the ‘discard 
pathway’ in TER1 biogenesis (Fig. 3.7A, B and Fig. 3.8B).  
 
 
	   76	  
 
	   77	  
Figure 3.7: Prp22 and Prp43 promote spliceosomal cleavage. (A) Northern Blot analysis 
of reporter containing wild type TER1 intron. RNA was isolated from prp22+ and 
prp22T665A cells initially grown at 32°C to 5 x 106 cells/ml, shifted to 22°C and harvested 
immediately. 1st step efficiencies were calculated as cleaved plus spliced form over all 
forms normalized to wild type at 32 °C multiplied by 100. 2nd step efficiencies were 
calculated as spliced form over cleaved plus spliced form normalized to wild type at 32 
°C times 100. Data represented as mean +/- SEM (n=3). (B) Northern blot analysis of a 
second Prp22 mutant prp22S663A. Analysis of TER1 processing as in (A) with N=3. (C) 
Analysis for prp43S229A and prp43R406N by northern blotting. Quantification as described 
in (A) with n=2. 
 
The Prp43 helicase functions downstream of Prp22 in the release of spliced mRNA as 
well as the discard of suboptimal splicing intermediates [112].  A mutation in budding 
yeast PRP43 further revealed a role in enhancing the specificity of exon ligation by 
repressing the use of a cryptic 3’ splice site.  Consistent with a role for S. pombe prp43 in 
TER1 processing, two mutations (Fig. 3.7C) also reduced first step and increased second 
step efficiencies for the TER1 reporter (Fig. 3.7C).  
 In summary, several RNA elements in the TER1 intron act cooperatively to attenuate the 
second step of splicing, thus creating an opportunity for the rejection and discard of the 
splicing intermediates in a Prp22 and Prp43-dependent manner.  
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Figure 3.8: Characterization of prp22 and prp43 mutant alleles.  (A) Schematic of Prp22 
domain structure. Amino acid change and position of mutations used in this study are 
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indicated above the bar. Start and end positions of known domains are shown as 
colored boxes and by amino acid position. Abbreviations: RNA binding domain (RB), 
helicase conserved C-terminal domain (HCD), helicase associated domain (HA2) and 
domain of unknown function 1605 (DUF1605). Spotting assay for strains harboring 
prp22+ or mutant alleles. Five fold dilutions of cultures were spotted in triplicates and 
plates were incubated at 22°C, 32°C and 36°C, respectively. Pictures were taken after 
the indicated number of days.  (B) Northern blot analysis of the reporter containing the 
wild type TER1 intron in the context of prp22+ and prp22H634A cells initially grown at 32°C 
to 5 x 106 cells/ml and then shifted to 22°C. Cells were harvested and RNA was isolated 
as soon as the culture reached 22°C.  (C) 1st step efficiencies were calculated as 
cleaved plus spliced form over all forms normalized to wild type at 32°C times 100. 2nd 
step efficiencies were calculated as spliced form over cleaved plus spliced form 
normalized to wild type at 32°C times 100. 
 
III.4: Discussion 
The realization that fission yeast telomerase RNA 3’ end processing is carried out by the 
first step of splicing was surprising at first.  The need to accurately remove thousands of 
introns from pre-mRNAs has resulted in tight coupling of the two steps of splicing, as to 
not inadvertently release the intermediates. Utilization of the first step of splicing as a 
means for 3’ end formation necessitates that splicing is aborted after the first cleavage 
reaction. Here we have shown how the spliceosome can be converted into a 3’ end 
processing machinery in the context of TER1 RNA: A combination of RNA elements 
that promote spliceosome assembly and the first step, but encumber the transition to the 
second step is sufficient to uncouple the two reactions and promote the release of the free 
5’ exon via the discard pathway.  In addition to providing further insights into the 
mechanism of telomerase biogenesis, these studies shed new light onto aspects of the 
splicing reaction that are still only poorly understood. 
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III.4.a: A conserved role for distance and Py-tract in regulating the second step.  
The most obvious feature that distinguishes the TER1 intron from the majority of introns 
in fission yeast is the distance between the BP and 3’ ss.  At 23 nucleotides, TER1 is in 
the top three percentile of introns with respect to BP to 3’ ss distance. Although, the BP 
to 3’ ss distance varies considerably between introns, there is a clear species-specific 
optimum into which the majority of introns fall. In budding yeast, the mean distance 
between BP and 3’ ss is around 39 [143, 146]. Increasing the distance in the context of a 
specific intron hampers progression through the second step [147, 148].  In humans, BP 
to 3’ ss distances also cluster in a fairly narrow window around 25 nucleotides [149, 
150], with the exception of a small number of introns that contain distant branch sites that 
can be greater than 150 nucleotides from the 3’ ss [128]. Altering the distance between 
BP and 3’ ss in the context of in vitro splicing substrates results in accumulation of 
splicing intermediates [92, 151]. So despite differences during spliceosome assembly 
between yeasts and metazoans, uncoupling of the two steps of splicing as a consequence 
of a long BP to 3’ ss distance has been observed in diverse systems.  
In vertebrates, binding of U2AF to the polypyrimidine tract promotes U2 recruitment 
[139, 140] and mutations that shorten the Py-tract or replace pyrimidines with purines 
interfere with spliceosome assembly [135, 152]. Similarly in fission yeast, the Py-tract 
has been shown to function prior to the first step of splicing [91].  Here, a preformed 
complex of SF1 and the small and large subunits of U2AF bind cooperatively to the BS, 
Py-tract and 3’ ss [134]. The prominent role of a Py-tract during the early stages of 
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splicing has complicated the analysis of its roles during the second step. However, 
synthetic splicing substrates containing competing splice sites revealed a function of the 
Py-tract in 3’ ss choice and second step kinetics [92]. Notably, completion of the second 
step was only dependent on a Py-tract in the context of a long distance between the BP 
and 3’ ss.  Similarly, in budding yeast, where introns were long thought not to contain 
functionally important Py-tracts, examination of model substrates revealed a critical 
function for uridine-rich motif in the identification and utilization of distant splice 
acceptor sites [153]. A role for Py-tracts in promoting the second step therefore appears 
to be widely conserved as well.   
What is more surprising is that a temperature sensitive allele of U2AF59 would 
compromise completion of the second step at the restrictive temperature (Fig. 3.4C).  At 
least in mammalian splicing extracts, the large subunit of U2AF is replaced by 3 proteins 
of the U5 snRNP prior to the second step of splicing [154] and is not detected in the C 
complex [155].  Fission yeast may differ in this regard or U2AF may remain transiently 
associated with the spliceosome and promote the second step even after direct 
interactions with the Py-tract has ceased.  
 
III.4.b: A strong branch site can impede completion of splicing. 
Binding of the U2 snRNP to the BS is one of the earliest, and in some cases the earliest, 
events in spliceosome assembly [156], and the extent of sequence complementarity 
correlates positively with the rate of assembly and first cleavage reaction [157].  
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Pioneering cross-linking studies in the early 1990s suggested that the U2 – BS 
association is maintained through both steps of splicing [144] and consistent with this 
assertion, the U2 snRNP remains part of the spliceosome after the first step [158]. What 
has remained puzzling in this regard is that BS mutations to either G or U inhibit the 
second step of splicing in yeast and human cell extract [159-162]. Using an orthogonal 
splicing system involving a highly substituted and reporter-specific second copy of U2, it 
has been shown that a change in the position of the bulged nucleophile imposes a block 
on the second step [163]. One interpretation of these results is that the nucleotide change 
affects the flexibility of the RNA and this impairs the conformational rearrangements that 
position the RNA correctly for the second transesterification reaction.  
An indication that the U2 – BS interaction may unwind prior to 5’ splice site cleavage 
came from the observation of trans-splicing products between the 5’ end of U2 and the 3’ 
exon of a reporter gene in budding yeast [164].  While those results indicated that U2 – 
BS base pairing is more dynamic than previously thought, it did not suggest that 
maintenance of the U2 – BS interaction is detrimental to the completion of splicing. Our 
analysis now showed that in the appropriate context sequence complementarity between 
the BS and U2 antagonizes the completion of splicing and favors uncoupling of the two 
steps. In light of these observations, it seems likely that at least partial or transient 
disruption of U2 – BS base pairing is part of the transition from the first to the second 
step of a normal splicing reaction. The molecular function of this rearrangement will need 
to be defined by future studies. 
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III.4.c: A ‘proofreading pathway’ generates functional telomerase RNA  
Our results show that a combination of intronic elements hamper the transition from the 
first to the second step of splicing and are critical for the release of the TER1 5’ exon 
after the first step of splicing. The implication of Prp22 and Prp43 in TER1 processing 
further suggests that the ‘discard pathway’ is not merely acting in the recovery of 
spliceosomes from defective or suboptimal substrates, but in the case of TER1 promotes 
the release of a functional product.   As the mechanism for attenuating the transition from 
the first to the second step as well as the molecular machinery are widely conserved, 
additional targets for this pathway are likely to be discovered. 
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Chapter Four:  
U6 hyper-stabilization with 5’ss generates the 3’ end of telomerase RNA 
in S. cryophilus and S. octosporus 
IV.1: Abstract 
The mature 3’ end of fission yeast telomerase RNA (TER1) is generated by spliceosomal 
cleavage akin to the first step of splicing. In the case of TER1, uncoupling the two steps 
of splicing is achieved via a combination of strong branch site interactions with U2 
snRNA and a long distance between branch point and 3’ss, which stimulates cleavage. 
Whether TER1 is unique in employing spliceosomal cleavage or other examples exist is 
unknown. We now demonstrate that the majority of uncoupling elements are selected 
against introns in protein coding genes. In addition, we have determined that telomerase 
RNA in S. cryophilus and S. octosporus are also cleaved. Unlike TER1, hyper-
stabilization of U6 snRNA with 5’ss impedes the 2nd step of splicing allowing cleaved 
form accumulation in S. cryophilus and S. octosporus. In summary, our studies indicate a 
general role for the spliceosome in telomerase RNA processing in fission yeast. 
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IV.2: Introduction 
Fine tuning RNA expression is a critical step in controlling gene expression [79].  The 
generation of mature RNA inside the cells is one of the most complicated events in all 
cell biology and biochemistry [80]. Not only is there an elaborate repertoire of proteins 
that direct RNA polymerase II to begin synthesis of precursor RNA, but in addition 
accurate processing and correct localization of mature RNA is equally, if not, more 
complex [80]. 
One of the pivotal events in RNA processing is precursor RNA splicing, which involves 
tight coupling of intron removal and exon ligation. In the first step of intron excision, the 
2′ hydroxyl of the branch point (BP) adenosine, located within the branch site (BS) 
sequence, attacks the sugar-phosphate bond at the 5′ splice site (5’ ss), forming a 2’-5’ 
linkage and producing a free 5′ exon and a branched species, termed the lariat 
intermediate [114].  In the second reaction, the now exposed 3′ hydroxyl of the upstream 
exon attacks the phosphate at the 3′ splice site (3’ ss), yielding ligated mRNA and the 
lariat form of the intron. The importance of studying splicing at a molecular level is 
illustrated by the finding that more than 30% of human diseases are caused due to 
mutation in splice sites or the spliceosome components [84].  
Intron removal from precursor RNA is catalyzed by the spliceosome, a mega dalton 
complex, whose assembly and function require transition between multiple 
conformations [90]. Based on accumulating genetic and biochemical data, we now 
understand that 5’ ss is positioned for first step catalysis via base pairing with the 
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conserved ACAGAG region of U6 snRNA while the region surrounding the branch point 
is paired with the conserved GUAGUA sequence of U2 snRNA. In addition, U5 snRNA 
interacts with both exons, maintaining optimum position required for catalysis.  
Notably, splicing studies have focused on protein encoding genes. There, a strong bias 
exists to select for tight coupling of the two transesterification reactions, as release of 
splicing intermediates after the first cleavage reaction would result in degradation and 
hence block gene expression [165]. Predictably, examining current splicing literature has 
led to the deduction that the two steps of splicing are normally linked to one another [95]. 
Telomerase is the ribonucleoprotein complex that synthesizes and maintains telomeres. 
The catalytic core of telomerase is composed of a non-coding RNA (TER) and protein 
subunit (TERT) which is the reverse transcriptase. Although many insights have been 
gained regarding telomerase function in telomere repeat addition and processivity, we 
know little about the biogenesis of telomerase in eukaryotes [62]. 
The fission yeast telomerase RNA harbors an intron immediately downstream of its 
mature 3’ end. Unlike canonical splicing, only the first step cleavage is required to 
generate mature TER1 [116]. Particularly, TER1 intron undergoes cleavage irrespective 
of the identity of the first and second exons [116, 165]. Conversely, replacement of 
TER1intron with a heterologous intron from a protein-coding gene leads to completion of 
splicing. Notably, the TER1 branch site is fully complementary to the BS binding 
sequence in U2 snRNA, whereas the BS in FCP1 intron 1 deviates by two nucleotides 
from the U2 complement, resulting in a mismatch and the replacement of a G-C base pair 
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with a G: U wobble. Indeed, restoring the two base pair interactions, promotes 
spliceosomal cleavage of the heterologous intron.  Furthermore, increasing the distance 
between branch point and 3’ ss to 38 nucleotides stimulated spliceosomal cleavage at the 
expense of splicing, whereas reducing the distance promoted the 2nd step of splicing. In 
essence, a strong branch site in the context of a long distance between branch point and 
3’ss impedes the 2nd step of splicing, triggering release of 5’ exon via Prp22 and Prp43 
mediated discard pathway [165]. The observation that intronic elements can prohibit the 
transition to the 2nd step of splicing to generate the 3’ end of a non-coding RNA suggests 
that other examples of cleaved RNAs could exist. However, the identity of these RNAs 
has been elusive. 
Here, we demonstrate that the majority of the introns present in protein coding genes in S. 
pombe have selected against uncoupling elements that promote spliceosomal cleavage. 
We demonstrate one example where an intron in a protein-coding gene is cleaved 
implicating a function for spliceosomal cleavage in regulating gene expression. Further, 
we establish that telomerase RNA in S. octosporus and S. cryophilus is processed by 
spliceosomal cleavage albeit via a different mechanism.  Our studies bring out new 
insights as to how the spliceosome can function in 3’ end processing. 
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 IV.3: Results 
IV.3.a: Global selection against spliceosomal cleavage. 
Sequence elements that hinder transition of the spliceosome during the second step of 
splicing will be detrimental for protein coding genes. To confirm the above hypothesis, 
we examined those fraction of annotated fission yeast introns that share the combination 
of a strong branch site, long distance and weak Py-tract and are therefore likely 
candidates for spliceosomal cleavage [165]. While the use of the spliceosome in 3’ end 
processing may be limited to non-coding RNAs, spliceosomal cleavage could also serve a 
function in regulating gene expression by reducing the amount of spliced mRNA that is 
produced [129].  
To identify putative branch sites we first used a Gibb’s sampler algorithm to identify 
motifs that are over-represented in S. pombe introns (excluding the 5’ and 3’ splice sites, 
see Experimental Procedures for details). The positional weight matrix (PWM) generated 
by this approach strongly resembled known branch sites (Fig. 4.1A).  We then used the 
PWM to score every position in the intron data set. This score (referred to as SBS) ranges 
from 1.0 to 7.86. Plotting the SBS values versus their positions relative to the acceptor site 
revealed that sites with scores > 6 clustered near the 3’ splice site (Fig. 4.2A) Only 189 
annotated introns (4%) returned no match for a site with SBS  > 6.0 and were excluded 
from further analysis. 42% had exactly one site with a score ≥ 6 and the remaining 54% 
had more than one such site (Fig. 4.2B). For introns with more than one site ≥ 6, the site 
closest to the 3’ ss was chosen as the putative BS.  
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Figure 4.1: Global analysis indicates selection against the intron structure that favors 
release after the first step of splicing. (A) Sequence logo representation of the S. pombe 
branch site PWM constructed as described in Experimental Procedures. (B) Histogram  
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showing the locations of branch sites relative to the 3’ splice site. A vertical arrow marks 
the position for TER1. (C) Pie chart representation of introns with long and short distance 
between BP and 3’ ss, respectively. (D) Graphical representation of the relationship 
between BS strength and distance to 3’ ss. (E) Scatter plot illustrating Py-tract strength 
for introns that resemble TER1 in BS sequence and distance to 3’ss.  (F) Northern blot 
for the reporter RNA containing the indicated introns. A probe against snR101 was used 
as loading control (LC). Data represented as mean +/- SEM with n=2. 
With putative branch sites mapped in this manner, the mean distance from BP to 3’ ss 
was 11 nucleotides (Fig. 4.1B), a finding that is in good agreement with the positions of 
predicted branch sites based on a subset of fission yeast introns [89]. For 96% of introns 
the distance was below 20 nucleotides and only 176 introns had a distance between the 
predicted BP and 3’ ss in the range of where we detect uncoupling of splicing for TER1 
(Fig. 4.1C). We next compared the strength of the branch sites between these introns and 
those with a shorter distance. Whereas 60% of introns with a BP located within 20 
nucleotides from the acceptor have strong predicted branch sites (defined as a score 
above 7.0), only 30% of introns with a distance greater than 20 nucleotides have strong 
branch sites (Fig. 4.1D). This statistically significant difference (χ2 p-value= 9.1x10-15) 
between these categories demonstrates that the combination of a strong BS and a long BP 
to 3’ ss distance is underrepresented in introns of protein encoding genes.   
We next plotted the uridine to pyrimidine ratio over the pyrimidine content as a measure 
of Py-tract strength for the 10 introns that share the consensus BS sequence with TER1 
and have a BP to 3’ ss distance of 20 or more nucleotides (Fig. 4.1E).  With the exception 
of MBX1 intron 3, all candidates have stronger Py-tracts than TER1.  The two introns 
that resembled TER1 most closely were cloned into the reporter construct and examined 
by northern.  No cleavage was observed for MBX1, but the free 5’ exon was readily 
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detected for ATP23 (Fig. 4.1F). To assess whether the cleavage of the ATP23 RNA was a 
consequence of placing the intron into a heterologous context, we examined the 
endogenous message in the context of wild type fission yeast and a rrp6 deletion. The 
latter compromises the activity of the nuclear exosome and is thus expected to stabilize a 
released 5’ exon. We indeed observed the spliceosomal cleavage product for ATP23 in 
both strain backgrounds (Fig. 4.2C). However, unlike TER1, the spliced form of ATP23 
RNA dominated over the cleaved form in steady state.  In summary, the combination of 
RNA elements that promote the uncoupling of the two steps of splicing is largely absent 
from the vast majority of annotated introns, but at least in one case cleaved pre-mRNA is 
detected. Importantly, the global analysis exposed a fervent anticorrelation between a 
strong branch site and a long BS – 3’ ss distance. 
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Figure 4.2: Branch site prediction and analysis of Atp23.  (A) Heatmap showing the SBS 
score (y-axis) for each intronic 10-base k-mer  versus  its relative position in the intron 
(x-axis). Only kmers with scores >  5.5 are shown. The relative position (relP) is the 
normalized position relative to the 3’ss (i.e. the number of nucleotides from the acceptor 
site divided by the length of the intron). (B) Bar graph based on the number of branch 
sites with SBS>6 found in each intron expressed as percentage of all introns. (C) Northern 
blot on total RNA isolated from wild type and rrp6D strains, subjected to RNaseH 
cleavage and probed for ATP23. (D) Comparison of BS strength between all sequences 
that match the PWM and the best match for each intron. 
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Considering that majority of introns in protein coding genes are selecting against 
uncoupling elements, we reasoned that if spliceosomal cleavage is essential for 
telomerase RNA processing, the mechanism should be conserved in closely related 
fission yeast species. With this in mind, we identified the telomerase RNA subunits in S. 
cryophilus and S. octosporus by sequence homology to TER1. Notably, both TERs 
contained intron like sequences beyond their 3’ end (Fig. 4.3A). To determine if these 
introns can promote spliceosomal cleavage, we replaced the S. pombe TER1 intron with 
introns from either S. cryophilus or S. octosporus. Despite displaying limited sequence 
homology, both introns promote spliceosomal cleavage indicating that the function for 
spliceosome in 3’ end processing is conserved in fission yeast (Fig. 4.3 B and C). 
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Figure 4.3: 3’ end processing of telomerase RNA is conserved among fission yeast 
species. A) Schematic of the intron sequences in the 3 different species. B) Northern 
blot analysis of ter1 constructs containing the different introns and the loading control 
(LC). B) RT-PCR across the intron to assess the abundance of the spliced form.  
IV.3.b: Hyper-stabilizing U6 snRNP with 5’ss promotes spliceosomal cleavage 
Next, we wanted to examine whether mechanism of telomerase RNA processing is 
conserved in the different species of fission yeast. Unlike TER1, both S. cryophilus and S. 
octosporus introns contain a short distance between the bp and 3’ss which will promote 
completion of splicing irrespective of the branch site strength [165]. We wondered if the 
requirement for a long distance between the bp-3’ss is offset by the presence of other 
uncoupling elements. Particularly, the unique aspect of both introns is the 5’ss 
GUCAGU, where the weak A-U base pair interaction at +3 position in the 5’ss is 
replaced with a strong C-G base pair interaction (Fig. 4.4B). Elegant studies in budding 
yeast has shown that increasing base pair interactions of 5’ss with U6 traps the 
spliceosome in the first step conformation, thereby inhibiting the 2nd step of splicing 
[166]. To test if U6 stabilization at 5’ss is essential for spliceosomal cleavage of S. 
cryophilus and S.octosporus TER, we changed the 5’ss to GUAAGU. Indeed, a single 
nucleotide change at the 5’ss, promotes potent completion of the 2nd step leading to 
accumulation of the spliced form at the expense of cleaved form (Fig. 4.4C and D). 
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Figure 4.4: Hyper-stabilization of U6 with 5’ss as an alternative method for spliceosomal 
cleavage. A) Schematic of the three different fission yeast telomerase RNAs B) 
Illustration of U6 binding to 5’ss C) RT-PCR of 5’ss mutants D) Northern blot of the 
different ter1 constructs carrying the fission yeast introns with or without 5’ss mutations. 
These observations demonstrate that the spliceosome has a conserved function in 
generating the 3’ ends of telomerase RNA in fission yeast. More importantly, it suggests 
there are multiple ways to promote cleavage over splicing, indicating uncoupling of the 
two steps of splicing could have a critical role in gene regulation and RNA processing.  
 
 
Figure 4.5: Model illustrating how sequences within the spliceosome can convert the 
function of spliceosome from splicing to 3’ end processing. 
IV.4: Discussion 
The realization that a combination of sequence elements can switch the function of 
spliceosome from splicing to 3’ end processing was surprising at first [165]. In the case 
of protein coding genes, uncoupling the two steps of splicing and releasing splicing 
intermediates will block gene expression. Here, we have shown that majority of protein 
coding genes in S. pombe alleviate this problem by maintaining a short distance between 
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bp and 3’ss, allowing completion of the two steps of splicing. Surprisingly, we 
demonstrate that weaker branch sites are selected in introns that contain a long distance 
between bp and 3’ss, presumably to prevent uncoupling the two steps of splicing. More 
importantly, we establish that spliceosomal cleavage is a general mechanism for 
telomerase RNA processing in fission yeast. In addition to providing insights into 
telomerase RNA biogenesis, these studies shed light on the mechanism of splicing in 
non-coding RNAs, which is still poorly understood. 
IV.4.a: Selection against uncoupling elements in S. pombe 
Pioneering studies established that UACUAAC is the preferred branch site for U2 
snRNA binding from yeast to humans, and hence essential for splicing [167]. Elegant 
crosslinking studies had demonstrated that U2 snRNP is associated with the intron until 
completion of splicing [168]. These studies had led to the conclusion that presence of a 
strong branch site promotes the first step of splicing and does not influence splicing 
afterwards. The first clue that U2 – BS interaction might be disrupted prior to the 5’ 
splice site cleavage came from the observation of trans-splicing products between the 5’ 
end of U2 and the 3’ exon of a reporter gene in budding yeast[164]. However, the 
significance of the disruption of U2-BS interaction has remained elusive. We have shown 
that a strong branch site is critical for inhibition of the 2nd step of splicing for TER1 
processing [165]. Whether disruption of U2-BS interaction is a general phenomenon for 
completion of splicing has remained elusive. To solve this conundrum, we analyzed 
genome wide the strength of branch sites in S. pombe. From these studies it is clear that 
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the inhibitory role of branch site is context dependent. Though introns with a short 
distance between bp and 3’ss can tolerate strong branch site, there is a bias against strong 
branch sites in introns with long distance between bp and 3’ss (Fig. 4.1). In light of our 
results and the observation that U2snRNP components SF3a and SF3b are destabilized 
after the first step of splicing [158, 169], suggests strong U2-BS interaction is detrimental 
for the second step of splicing. 
Furthermore, at least for one intron that contained the uncoupling elements, we detected a 
cleaved isoform in a protein-coding gene Atp23 indicating that spliceosome could 
function in reducing the levels of mRNA thereby playing a critical role in gene 
regulation. Nevertheless, there exists a fervent anti-correlation between the strength of 
branch site and distance between bp and 3’ss. 
IV.4.b: U6 hyper-stabilization with 5’ss generates 3’ end of telomerase in S. cryophilus 
and S. octosporus 
The identification that the spliceosome generates the mature form of telomerase RNA in 
S. pombe led to the question how general is this mechanism for TER processing. With 
this intention, we identified the telomerase RNA in closely related species of S. 
cryophilus and S. octosporus. Despite displaying little sequence similarity, the telomerase 
RNA introns from S. cryophilus and S. octosporus are cleaved efficiently in the context 
of TER1, demonstrating a conserved role for the spliceosome in TER processing across 
fission yeast species. 
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For promoting cleavage over splicing, S. pombe TER1 utilizes a combination of a strong 
branch site and a long distance between bp and 3’ss [165]. In contrast, those uncoupling 
elements are absent in other species of fission yeast. Instead, both TER undergoes 
extensive base pair interactions with U6 snRNA via their 5’ss, thereby stabilizing the first 
step conformation and impeding the second step. 
These observations add to the growing evidence that supports the ‘two state’ model of the 
spliceosome [170]. It is now clear that the spliceosome has to transition between the two 
conformations to catalyze the two transesterifications. Our finding is reminiscent of 
studies in budding yeast where stabilizing U6 snRNA base pair interaction with 5’ss in 
the context of a protein coding gene inhibits the transition to the second step [166]. On 
the other hand, weakening the 5’ss base pair interaction with U6 allows completion of 
splicing. 
In essence, these studies suggest that extensive base pair interaction of either U2 or U6 
with branch site and 5’ss respectively, can inhibit transition to the second step, thereby 
promoting release of the 5’ exon via the discard pathway (Fig. 4.5). Furthermore, these 
results also indicate that spliceosomal cleavage rather than identity of sequence elements, 
is under strong selective pressure for telomerase RNA processing in fission yeast. The 
observation that introns are present beyond the 3’ ends of telomerase RNAs in several 
species of Candida and Aspergilli also suggest that spliceosome has a general function in 
telomerase RNA processing in yeast and filamentous fungi [127, 171]. 
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IV.4.c: Implications for evolution of splice sites 
Considering the indispensable role for U6 and U2 snRNA in splicing, the splice site 
binding regions, ACAGAG in U6 and GUAGUA in U2 are essentially identical from 
yeast to humans [95]. In contrast, the 5’ss and branch sites are loosely conserved in 
mammals. Furthermore, recent studies that sequenced the lariat of housekeeping genes in 
humans identified the branch sites to be extremely degenerate [172]. Although, this 
paradox has been noted earlier the exact reasons has not been established [167]. Our 
observation demonstrating that extensive base pair interactions between 5’ss and U6, BS 
and U2 can uncouple the two steps of splicing, suggests introns in protein coding genes 
have evolved to allow coupling of the two steps at the expense of splice strength. In 
conclusion, our studies establish that introns in non-coding RNAs and mRNAs have 
evolved different sequences that enable them to utilize the spliceosome for 3’ end 
processing or splicing, respectively. 
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Chapter Five: 
Conclusion and Future directions 
 
V.1: Significance of using spliceosomal cleavage for 3’ end processing 
Research examining how linear chromosome ends solve the ‘end protection’ and the ‘end 
replication’ problems has been one of the most fruitful areas of science. Within this field, 
vast knowledge has been gained about how telomeres and telomerase allow eukaryotes to 
safely maintain linear chromosome ends. In addition, critical roles for telomeres and 
telomerase in cancer and degenerative diseases have been uncovered. The rapid progress 
in our understanding of telomerase was possible due to the insights obtained from model 
organisms. Although, many key concepts and principles have emerged regarding the role 
of telomerase in telomere maintenance, we still know little about how telomerase 
biogenesis occurs in eukaryotes. Since small nuclear RNA are extremely conserved 
between S. pombe and humans [173], elucidating TER1 processing provided an excellent 
tool not only for uncovering telomerase biogenesis, but also for probing aspects of non-
coding RNA processing that remain unclear. 
The observation that only the first step of splicing is required for TER1 processing was 
surprising initially. From elucidating splicing mechanism in protein coding genes, it was 
clear that the two steps of splicing are tightly coupled. However, in this context, release 
of splicing intermediates will lead to degradation and thereby block gene expression. 
Nevertheless, due to the contrasting pieces of evidence in hand, we decided to solve a 
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major question plaguing the field: How is the spliceosome converted into a 3’ end 
processing machinery? 
The key for dissecting RNA elements that promote the first step of splicing but hinder the 
second step, was the development of a reporter system in which similar levels of spliced 
and cleaved form are produced and can be quantified in a direct assay. Using this unique 
approach, we have shown that a long distance between the branch point and 3’ss inhibits 
the second step of splicing. More importantly, we have demonstrated that strong branch 
site base pair interactions with U2 snRNA can uncouple the two steps of splicing and the 
5’ exon can be released via the discard pathway. These observations lead to critical 
questions which is the major contribution of the research in Chapter Three and Four to 
the fields of RNA processing, splicing and telomerase biogenesis. 
One of the most pressing questions put forth in Chapter Three and Four is why the 
spliceosome is used to generate 3’ ends of telomerase RNA when other energy efficient 
ways are available? In other words, are there conditions in which splicing can be 
completed allowing an elegant way to control telomerase levels. Studying conditions in 
which telomerase activity is no longer required would be an obvious starting point. S. 
pombe cells grow rapidly in log phase when plenty of nutrients are available. However, 
cell division slows down with decrease in nutrient availability and halts on reaching 
stationary phase. Since telomerase promotes cell proliferation, it is possible that it is 
actually detrimental for stationary phase progression and must be turned off. Preliminary 
experiments indicate that the spliced form of telomerase RNA accumulates as cells enter 
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stationary phase (Fig. 5.1B). In contrast, Prp43 mRNA levels decrease during the same 
time period consistent with the finding in Chapter Three that Prp43 hinders the second 
step of splicing (Fig. 5.1A). 
Reduction in levels of prp 43
Increase in levels of spliced TER1
Northern for prp43 mRNA
RT-PCR for TER1
A
B
(increasing time points 
as cell enter stationary phase 
from right to left)
 
 Figure 5.1: Spliced form increases in stationary phase. A) Northern blot of total RNA 
isolated from wild type cells at increasing time points as cells enter stationary phase and 
probed for Prp 43 mRNA. B) RT-PCR detecting the precursor and spliced forms of TER1 
in the same time points as A. 
 
With this observation as a starting point, one could perform a series of experiments to test 
if spliceosomal cleavage is used to regulate telomerase levels. An important limitation in 
studying the function of spliced form is that despite being polyadenylated, it is extremely 
unstable suggesting that additional mechanisms exist within the cell to ensure low levels 
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of spliced TER1. We have shown that the nuclear exosome component Rrp6 
downregulates spliced TER1 (data not shown). Thus, spliced form can be stabilized, by 
expressing ter1-55 mutant, which promotes completion of splicing, in a rrp6 deletion 
strain. In this context, we can examine if telomerase is functional by performing a 
Southern blot to determine telomere length. In addition, telomerase activity assays can 
provide insights whether the spliced form can support catalysis. In summary, experiments 
suggested here can pinpoint if spliceosomal cleavage regulates telomerase RNA levels in 
different cellular conditions.  
V.2: Role for spliceosomal cleavage in controlling mRNA levels 
Generally speaking, transcriptional networks play an important role in controlling gene 
expression[174]. However, some genes must be regulated in response to sudden changes 
in environment, and achieving this via transcription is difficult. Equally important, RNA 
processing provides additional layers of regulation thereby fine tuning gene expression  
[79, 80]. Considering this point, the detection of a cleaved form for at least one protein 
coding gene, Atp23, suggests that spliceosomal cleavage may be required for controlling 
mRNA levels. 
Under circumstances in which an excess amount of protein is detrimental to the cell, the 
ability to cleave and degrade the 5’ exon, thereby lowering the amount of mRNA 
available for translation, would allow the cells to rapidly adapt to environmental changes. 
An obvious experiment to test this hypothesis and continue from the results obtained in 
Chapter Four is to replace the cleaved intron with a well spliced intron to examine 
	   106	  
whether completion of splicing is detrimental to the corresponding cellular process. The 
change in splicing can be measured by quantitative RT-PCR and protein expression can 
be detected via western blotting. In essence, these experiments will not only suggest new 
insights on gene regulation but will change our approach regarding function of introns in 
protein coding genes. 
In light of our findings in Chapter Three and Four, the notion that spliceosomal cleavage 
may have non-canonical functions in controlling gene expression is gaining momentum. 
For example, it has been discovered that introns that undergo a slow 2nd step of splicing, 
are the source of small silencing RNA in the opportunistic fungal pathogen Cryptococcus 
neoformans[175]. Due to suboptimal intronic sequences, the spliceosome stalls on the 
substrate mRNAs after the first step of splicing. Following the arrest, the spliceosome 
coupled and Nuclear RNAi complex (SCANR) uses the debranched lariat intermediate as 
a template for small-RNA biosynthesis which feeds into the silencing machinery and 
down regulates spliced mRNA. In summary, our studies are shedding light on the non-
canonical functions of the spliceosome in regulating gene expression. 
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Figure 5.2: A spliceosome-based source of small RNAs programs the silencing 
machinery in C. neoformans, adapted from [176]. Suboptimal introns with slow second 
step of splicing stall the spliceosome and the lariat intron is used as a substrate for 
generating small RNAs for RNA silencing. The resulting small RNAs are incorporated 
into the RNA interference-silencing complex (RISC) that degrades spliced form. 
V.3: Implications for Telomerase RNA processing in eukaryotes 
Though spliceosomal cleavage could have additional functions in controlling telomerase 
expression and gene regulation, the results obtained in Chapter Three and Chapter Four 
point towards a general role for the spliceosome in telomerase RNA and possibly non-
coding RNA processing. More importantly, the conservation of intronic sequences in 
recently identified TER from Candida and Aspergilli indicate that spliceosomal cleavage 
is a near obligatory mechanism for telomerase RNA processing at least in lower 
eukaryotes. Although it seems redundant, dissecting the sequence elements required for 
splicing uncoupling in Candida and Aspergilli TER will be crucial for elucidating aspects 
of the splicing mechanism that are only poorly understood [127, 171].  
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Similar to TER1, longer polyadenylated forms have been detected for human telomerase 
RNA (hTR) but whether they are precursors is unclear. As discussed earlier, the 
degenerate splice sites in higher eukaryotes makes it extremely difficult to identify 
introns in humans. The main evidence pointing towards a function for spliceosome in 
hTR processing stems from studies in which inhibition of the spliceosome using the drug 
isoginketin [177] yields accumulation of precursor (Gaspari M and Baumann P, 
unpublished). However, this may be due to an indirect effect and further research is 
required to dissect this problem. Considering that U2 snRNA in S. pombe and humans are 
remarkably similar [173] and Prp22, Prp43 are conserved in humans, manipulating these 
components could provide novel insights into hTR processing [178, 179]. 
One argument against extrapolating the data in S. pombe to humans is that the mode of 
spliceosome assembly is different between the two. Due to the large size of human 
introns, spliceosome assembly occurs by exon definition, whereas short introns in S. 
pombe can be recognized by intron definition. Although, the mode of intron recognition 
is different, the mechanism of catalysis is essentially identical from yeast to humans [95]. 
For example, it has been shown in vitro using human splicing extracts, that increasing the 
distance between branch point and 3’ss to 66 nucleotides in the context of pADml 
reporter system, leads to uncoupling of the two steps of splicing [92] (Kannan, R and 
Baumann, P; unpublished). However, to uncover the role of the branch site in this regard, 
a systematic analysis similar to those performed in budding yeast and S. pombe is 
essential. Considering this point, a recent study sequencing lariats of human introns has 
revealed a strict distance constraint for the branch point from the 3’ss, irrespective of the 
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total length of the intron [172]. In conclusion, these results indicate that insights obtained 
from S. pombe splicing can enhance our understanding of the human spliceosome.  
V.4: To determine other RNAs that are processed by spliceosomal cleavage 
The observation that either U6 hyper-stabilization with 5’ss or strong branch site base 
pair interactions with U2 snRNA can impede the transition to the second step of splicing 
thereby promoting 5’ exon accumulation indicates different mechanisms are in place for 
promoting spliceosomal cleavage. For uncovering other RNAs that are cleaved, the 
obvious candidates would be non-coding RNAs that contain introns. In most conditions, 
the cleaved 5’ exons would be degraded. In contrast, if the 3’ ends are stabilized by 
proteins similar to TER1 or due to formation of higher order structures [180], 
spliceosomal cleavage could result in a functional non-coding RNA. 
To identify non-coding RNAs that are cleaved, we can apply the knowledge gained from 
Chapters Three and Four. We know that a cleaved 5’exon would lack a polyA tail and 
hence be degraded by the nuclear exosome. However, a major problem in enriching 
noncoding RNA is the contamination of ribosomal RNA. Thus, in the context of rrp6 
deletion, depleting mRNA and ribosomal RNA from total RNA thereby enriching non-
polyadenylated RNA within the cell, will be the first step in identification of cleaved 
RNAs. Furthermore, to determine the 3’ end of cleaved form, we can add polyA tail in 
vitro using poly A polymerase and perform deep sequencing of the samples. Our goal 
would be to identify RNAs that end ahead of the 5’ss. Once identified, we can make 
mutations in the splice sites to test if the RNA is actually generated by spliceosomal 
cleavage. In summary, these results are expected to improve our understanding of 
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telomerase RNA biogenesis and possibly other non-coding RNA biogenesis in S. pombe 
and potentially humans. 
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